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Proper folding of protein molecules into their native structure is necessary to 
maintain function. Misfolding of proteins can reduce functionality as well as result in the 
formation of amorphous aggregates or ordered aggregates like amyloids. Amorphous 
aggregate formation during production, transport, and storage of protein-based biologics is 
a cause of concern in the biopharmaceutical industry as it results in a reduction in the 
efficacy or activity of the active pharmaceutical ingredient. On the other hand, ordered 
aggregation of proteins into amyloids (and their transmissible versions, prions) has been 
shown to result in several neurodegenerative diseases in humans and other mammals. 
While the effect of co-solutes including ions has been extensively studied in the context of 
measuring the stability of protein formulations and formation of disordered aggregates, 
there is limited information available on the effect of ions on the formation of ordered 
amyloid aggregates. In this thesis, we have investigated in detail the effect of presence of 
ionic co-solutes on the aggregation of amyloids. 
Here, we have studied the efficiency of cross-transmission of the NM fragment of 
Sup35 protein, from three closely related species of the Saccharomyces sensu stricto group, 
namely S. cerevisiae, S. bayanus and S. paradoxus, amongst each other. Using ions of the 
Hofmeister series, we discerned the relative effects of protein sequence, seed conformation, 
and environment on the cross-species transmission of this protein. Further, investigation of 
the fibrillation of Amyloid beta-42 (Aβ42) and Sup35NM in the presence of anions of the 
Hofmeister series at pH above and below their isoelectric points uncovered interesting 
differences in their aggregation behavior pointing to key differences in the aggregation 
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mechanism and the biophysical/biochemical properties of these proteins. Lastly, we 
developed a computational model for amyloid aggregation kinetics and used it for global 
fitting of Sup35NM amyloid aggregation data. In all, this thesis expands the current 
knowledge of ion-specific effects on aggregation of amyloid proteins as well as of the 






CHAPTER 1. INTRODUCTION 
Proteins are an important class of biomolecules which carry out a variety of 
biological functions like biocatalysis, transport, storage, motility, regulation or signal 
transduction, etc. The functionality of proteins depends on proper folding into a three-
dimensional structure. If a protein is not correctly folded into its native functional 
conformation, then its ability to perform its function is compromised. Reasons for improper 
or incomplete folding of a protein include mutations in the gene encoding the protein, 
mistakes by the translation machinery or ribosome, and external stresses such as high 
temperature, oxidative stresses, etc. Misfolding of proteins can result in aggregation as a 
consequence of minimizing the energetic penalty of exposing certain amino acid residues 
or due to attractive forces between some regions on the protein. Living organisms have 
mechanisms in place to ensure proper folding and prevent aggregation of proteins. 
Chaperones are a class of ‘helper’ proteins which constitute the biological machinery that 
assists in the protein folding process. Chaperones act through different mechanisms such 
as providing a favorable local environment for folding, preventing collapse and 
aggregation of partially unfolded regions, and catalyzing folding. Misfolded and 
aggregated proteins can be detrimental to cellular function and are targeted for degradation 
by the ubiquitin-proteasome system or through vacuolar proteolysis so that the amino acid 
precursors can be recycled and to rid the cells of damaged and dysfunctional proteins. Thus, 
chaperones and protein degradation machinery are central to maintaining protein quality 
control in vivo and ensuring that cellular proteins are functional which in turn is crucial for 
proper cellular functioning. 
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1.1 Protein folding, misfolding, and aggregation 
The process of protein folding consists of three steps. First step is the fast collapse 
or the burst phase, during which the polypeptide chain folds into a molten globule which 
has a secondary structure and some super secondary structure. This process typically occurs 
on the time scale of milliseconds. The burst phase is followed by intermediate folding 
where a tertiary structure is formed on the order of milliseconds to seconds. Finally, the 
protein folds to the final native state in less than a second.  The dynamics of protein folding 
is depicted by the folding funnel diagram shown below in Figure 1.1.  
 
Figure 1.1 – Thermodynamics of protein folding depicted as a free-energy funnel [1] 
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Protein folding to the lower free-energy native state is a thermodynamically 
favorable reaction. However, the protein molecule can get trapped in any of the states 
which correspond to the various local minima along the free energy folding landscape to 
the native state. Such partially folded or misfolded states often tend to form aggregates 
which can be amorphous or ordered in nature.   
The various fates of a newly synthesized protein are depicted in Figure 1.2 
 
Figure 1.2 – A unified view of some of the types of structure that can be formed by 
polypeptide chains [2] 
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1.1.1 Amorphous and Ordered Protein Aggregation 
Amorphous aggregates are generally formed by misfolded or partially folded 
proteins with exposed hydrophobic residues. The protein molecules try to minimize the 
energetic penalty due to exposure of these residues in an aqueous polar environment by 
associating together and hiding the hydrophobic residues inside the aggregate mass. 
Disordered or amorphous aggregation can occur as a consequence of denaturation of 
proteins by denaturing agents such as urea, high temperature, acidic or basic conditions 
etc. 
While most proteins have been shown to form amorphous aggregates, only a special 
class of proteins can form ordered, amyloid-like fibrous aggregates under moderate 
conditions. These amyloidogenic proteins can undergo a conformation change into an 
alternate, stable, and self-transmissible 𝛽𝛽-sheet rich configuration [3-6]. The amyloid 
conformation lends the protein molecules a tendency to associate with other protein 
molecules through 𝛽𝛽-sheet interactions and form ordered fibrous aggregates. The 
aggregation process is generally considered to proceed via a monomer addition mechanism 
where the incoming non-amyloid monomer undergoes a conformational conversion to the 
amyloid form as it adds to the amyloid polymer. While amyloids form a unique class of 
proteins which form these ordered fibrous aggregates under moderate conditions, many 
other proteins have been also shown to form amyloid-like aggregates under extreme 
conditions like very high or low pH or temperature [2].  
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A more inclusive depiction of the folding landscape shows how proteins can get 
trapped as amorphous or ordered aggregates which represent alternate stable minima 
besides the native state (see Figure 1.2). 
 
 
Figure 1.3 – Energy landscape scheme of protein folding and aggregation [7] 
In addition to being an energetically unfavorable occurrence in vivo, protein 
aggregation can also be highly toxic to the cells. For example, the formation of amyloid 
aggregates can result in a number of diseases in mammals. Protein aggregation is also an 
undesirable occurrence during the synthesis, purification, formulation, and storage of 
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protein based biopharmaceuticals, such as enzymes, antibodies, etc. Aggregates are 
detrimental because they reduce efficacy or activity of the desired protein, are aesthetically 
undesirable, and, most importantly, may incite an immunogenic response within the patient 
[8-10].    
1.2 Amyloids/Prions 
Amyloids which have been shown to be transmissible from one organism to another 
are called prions (Proteinaceous Infectious Particles). The nature of these infectious agents 
and their mechanism of transmission had evaded scientists for a long time until they were 
identified to be proteins [11, 12]. There are about 40 genetic or sporadic amyloid diseases 
in humans. Amyloids and prions are involved in several neurodegenerative diseases in 
mammals, namely Alzheimer’s disease, Parkinson’s disease, Creutzfeldt-Jakob disease, 
kuru, bovine spongiform encephalopathy, scrapie, chronic wasting disease etc. as well as 
other diseases such as diabetes mellitus type-II, atherosclerosis, etc. [13-18]. Nevertheless, 
it is important to note that not all amyloids cause diseases. Self-assembled amyloids or 
amyloid-like protein assemblies also perform biological roles such as in scaffolding of 
covalent polymers e.g. in melanin, spider and insect silk, and long term memory in 
Drosophila [19, 20]. Consequently, there is a lot of interest in studying the aggregation 
properties of this curious class of proteins.  
Several prions have also been identified in yeast. However, whether yeast prions 
cause disease like mammalian prions is a topic of debate in the scientific community [21, 
22]. It is widely believed that yeast prions act as non-Mendelian elements of inheritance 
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[23-26]. Yeast prions have been extensively studied and the “protein only” model for prion 
transmission was proven in yeast [27]. 
1.2.1 Methods for studying amyloid aggregation  
The most common and straightforward techniques for monitoring amyloid 
aggregation involve the use of dyes such as Thioflavin T, Congo red, ANS, and 
oligothiophenes, which bind to protein molecules present in the amyloid state and exhibit 
enhanced fluorescence or birefringence [28, 29]. Fluorescence/absorbance data obtained 
using dyes for simple non-seeded amyloid aggregation generally follows a sigmoidal 
behaviour as shown in Figure 1.4 
 
Figure 1.4 – Typical sigmoidal amyloid aggregation curve 
Other methods that track the fiber/aggregate fraction include direct absorbance or 
turbidity measurements. Light scattering is generally used to monitor the size of the 
aggregates but runs into the issue of the sample becoming highly polydisperse as more and 
more aggregates are formed. Microscopic techniques such as transmission electron 
microscopy, atomic force microscopy and fluorescence microscopy of labelled 
proteins/peptides are widely used to image aggregates. Other qualitative techniques include 
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analysing the insolubility of aggregate sample in the presence of detergents like SDS, 
analysing protease resistance, and electrophoresis techniques such as SDS-PAGE, SDD-
AGE (Semi-Denaturing Detergent Agarose Gel Electrophoresis), and capillary 
electrophoresis, etc [30]. 
1.2.2 Factors affecting amyloid aggregation 
The main factors which affect the amyloid aggregation process are the primary 
sequence of the protein and environmental conditions such as temperature, pH, presence 
of co-solutes, or agitation. [31-34]. Rubin et al. 2013 demonstrated ion-specific effects on 
the aggregation process of the prion domain containing fragment of Sup35 protein from 
Saccharomyces cerevisiae [32]. It was shown that ions influenced both the aggregation 
kinetics as well as the structure of the aggregates as observed by AFM and TEM analysis. 
Further, aggregates formed in the presence of different ions resulted in phenotypically 
different characteristics when transfected into yeast cells. Sup35NM has also been shown 
to form different strains of [PSI+] when nucleation occurs at different temperatures [34-
36]. Tanaka et al. 2004 studied the effect of temperature on aggregation of Sup35NM from 
Saccharomyces cerevisiae and found that a lower temperature (4°C) resulted in faster 
kinetics and phenotypically “strong” variant while a high aggregation temperature (37°C) 
resulted in slower kinetics and a phenotypically “weak” variant when transfected into 
Saccharomyces cerevisiae [34].  
1.2.3 Hofmeister Series  
The effect of ions on protein solubility and conformation was first studied by the 
Czech scientist, Franz Hofmeister, in the 1888. He arranged anions and cations based on 
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their ability to salt out (precipitate) hen egg white lysozyme. This arrangement of ions is 
termed as the Hofmeister series [37]. The complete series as discovered in Hofmeister’s 
original work is given below [38]. 
Hofmeister series of anions 
SO42- > HPO42- > CH3CO2- > C3H5O(CO2)33- > C4H4O62-  > HCO3- > CrO42- > Cl- > NO3- 
> ClO4-  
Hofmeister series of cations:  
Li+ > Na+ > K+ > NH4+ > Mg2+        
A lower concentration of the ions on the left of both the series were required to 
precipitate the protein while a higher concentration of the ions on the right was required 
for precipitation. Today, these series have been extended to other ions and the ions are 
usually arranged as per the ability to stabilize the native structure of proteins. In general, 
the ions which are larger in size, weakly hydrated, less polarized, decrease surface tension, 
and increase protein solubility are called ‘chaotropes’ while the smaller, strongly hydrated 
ions which increase surface tension and decrease protein solubility, favoring the most 
compact conformation are called ‘kosmotropes’. While the underlying mechanism of how 
ions stabilize/destabilize protein structure is not completely know, two main hypotheses 
have been considered. The first is based on the ability of ions to make and break hydrogen 
bonds (hence the terms ‘chaotropes’ or ‘water structure breakers’ and ‘kosmotropes’ or 
‘water structure makers’). However, this idea has been challenged by studies that reveal 
that influence of salts beyond the second solvation shell is not enough to account for their 
 10 
effects on protein structure [39-41]. The second hypothesis suggests that dispersion forces 
play a significant role in ion effects [42, 43].  
Previous work from our group has shown that the effect of ions on the aggregation 
kinetics and the structure of the amyloid aggregates formed by the prion domain containing 
NM fragment of the protein Sup35 from Saccharomyces cerevisiae at a pH of 7.4 correlates 
very well with their position in the Hofmeister series [31, 32].  
1.3 Proteins in this Study 
In this study, we have mainly worked with two proteins namely, yeast prion protein, 
Sup35 and human Amyloid beta42 (Aβ42). 
1.3.1 Sup35p 
Prions act as protein-based elements of inheritance in yeast. [PSI+] is one such yeast 
prion which results from the conformational change of cellular Sup35 protein to the prion 
form [44-46]. Sup35 is a subunit of the eukaryotic translation termination factor, eRF3. 
The conversion to [PSI+] causes loss of functionality resulting in reduced translational 
termination fidelity and nonsense read through. Since its discovery Sup35, has served as a 
model for studying the formation and propagation of amyloid aggregates [25, 47]. 
Sup35 can be divided into 3 segments –N (N-terminal domain), M (middle domain), and 
C (C-terminal domain). The N fragment is responsible for the prion characteristics of 
Sup35, the C fragment is responsible for its translation termination function and the 




Figure 1.5 – Domains of Sup35 and their amino acid compositions [45] 
The NM fragment of Sup35 is widely used to study amyloid formation in vitro since 
the N fragment alone is difficult to express and purify, is insoluble and aggregates too fast. 
Here, we have used Sup35NM as a model protein in all the sub aims of this thesis. 
1.3.2 Amyloid beta42 (Aβ42) 
Aβ42 is a 42 amino acid-long peptide formed by the proteolytic cleavage of amyloid 
precursor protein (APP). It is considered to be the causal factor for Alzheimer’s disease 
[48-51]. It forms fibrillar aggregates which associate together resulting in the formation of 
amyloid plaques in the central nervous system of the patient and lead to neuronal cell death 
and degeneration. Recent work on demonstrating the structure of Aβ42 fibers has shown 
that in the fibrillar form the peptide buries its hydrophobic residues in the core of 
symmetrical dimers that are stacked perpendicular to the axis of the fiber [52, 53].   
1.4 Map of this Dissertation 
 This thesis is organized in the following manner. Chapter 2 describes studies done 
to understand the main factors affecting the cross-species transmission of Sup35NM 
between three closely related Saccharomyces species. The environment of aggregation and 
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the seed ‘strain’ were modulated with the help of ions to investigate the relative impact of 
the protein sequence, strain, and environment on co-aggregation. Chapter 3 looks at the 
specific effects of ions on the aggregation kinetics of Sup35NM and Aβ42 in vitro at pH 
values above and below the isoelectric points of the two proteins. Electrophoretic mobility 
measurements were also done to determine how ions interact with the proteins and 
understand the relative differences in the aggregation behavior of these two proteins. 
Chapter 4 discusses the development of a simulation-based computational model for 
amyloid aggregation kinetics. The model is compared with existing models that have been 
used for fitting aggregation data collected for other proteins.  
1.5 References 
1. Boyle, J., Lehninger principles of biochemistry (4th ed.): Nelson, D., and Cox, M. 
Biochemistry and Molecular Biology Education. Vol. 33. 2005: John Wiley & Sons 
Inc. 74-75. 
2. Dobson, C.M., Protein folding and misfolding. Nature, 2003. 426(6968): p. 884-
890. 
3. Prusiner, S.B., Prions. Proceedings of the National Academy of Sciences, 1998. 
95(23): p. 13363-13383. 
4. Pan, K.-M., M. Baldwin, J. Nguyen, M. Gasset, A. Serban, D. Groth, I. Mehlhorn, 
Z. Huang, R.J. Fletterick, and F.E. Cohen, Conversion of alpha-helices into beta-
sheets features in the formation of the scrapie prion proteins. Proceedings of the 
National Academy of Sciences, 1993. 90(23): p. 10962-10966. 
5. Nguyen, J., M.A. Baldwin, F.E. Cohen, and S.B. Prusiner, Prion Protein Peptides 
Induce. alpha.-Helix to. beta.-Sheet Conformational Transitions. Biochemistry, 
1995. 34(13): p. 4186-4192. 
6. Ross, E.D., A. Minton, and R.B. Wickner, Prion domains: sequences, structures 
and interactions. Nature cell biology, 2005. 7(11): p. 1039-1044. 
7. Hartl, F.U. and M. Hayer-Hartl, Converging concepts of protein folding in vitro 
and in vivo. Nat Struct Mol Biol, 2009. 16(6): p. 574-81. 
 13 
8. Wang, W., S.K. Singh, N. Li, M.R. Toler, K.R. King, and S. Nema, Immunogenicity 
of protein aggregates—concerns and realities. International journal of 
pharmaceutics, 2012. 431(1): p. 1-11. 
9. Hermeling, S., D.J. Crommelin, H. Schellekens, and W. Jiskoot, Structure-
immunogenicity relationships of therapeutic proteins. Pharmaceutical research, 
2004. 21(6): p. 897-903. 
10. Rosenberg, A.S., Effects of protein aggregates: an immunologic perspective. The 
AAPS journal, 2006. 8(3): p. E501-E507. 
11. Prusiner, S.B., Novel proteinaceous infectious particles cause scrapie. Science, 
1982. 216(4542): p. 136-144. 
12. Kocisko, D.A., J.H. Come, S.A. Priola, B. Chesebro, G.J. Raymond, P.T. Lansbury, 
and B. Caughey, Cell-free formation of protease-resistant prion protein. 1994. 
13. Chiti, F. and C.M. Dobson, Protein misfolding, functional amyloid, and human 
disease. Annu. Rev. Biochem., 2006. 75: p. 333-366. 
14. Eisenberg, D., R. Nelson, M.R. Sawaya, M. Balbirnie, S. Sambashivan, M.I. 
Ivanova, A.Ø. Madsen, and C. Riekel, The structural biology of protein 
aggregation diseases: Fundamental questions and some answers. Accounts of 
chemical research, 2006. 39(9): p. 568-575. 
15. Gregersen, N., P. Bross, S. Vang, and J.H. Christensen, Protein misfolding and 
human disease. Annu Rev Genomics Hum Genet, 2006. 7: p. 103-24. 
16. Jackson, G.S. and A.R. Clarke, Mammalian prion proteins. Current opinion in 
structural biology, 2000. 10(1): p. 69-74. 
17. Höppener, J.W., M.G. Nieuwenhuis, T.M. Vroom, B. Ahrén, and C.J. Lips, Role of 
islet amyloid in type 2 diabetes mellitus: consequence or cause? Molecular and 
cellular endocrinology, 2002. 197(1): p. 205-212. 
18. Westermark, P., G. Mucchiano, T. Marthin, K.H. Johnson, and K. Sletten, 
Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. The 
American journal of pathology, 1995. 147(5): p. 1186. 
19. Fowler, D.M., A.V. Koulov, W.E. Balch, and J.W. Kelly, Functional amyloid–from 
bacteria to humans. Trends in biochemical sciences, 2007. 32(5): p. 217-224. 
20. Maury, C., The emerging concept of functional amyloid. Journal of internal 
medicine, 2009. 265(3): p. 329-334. 
21. McGlinchey, R.P., D. Kryndushkin, and R.B. Wickner, Suicidal [PSI+] is a lethal 
yeast prion. Proceedings of the National Academy of Sciences, 2011. 108(13): p. 
5337-5341. 
 14 
22. Shorter, J. and S. Lindquist, Prions as adaptive conduits of memory and 
inheritance. Nature Reviews Genetics, 2005. 6(6): p. 435-450. 
23. Wickner, R.B., H.K. Edskes, M.-L. Maddelein, K.L. Taylor, and H. Moriyama, 
Prions of yeast and fungi Proteins as genetic material. Journal of Biological 
Chemistry, 1999. 274(2): p. 555-558. 
24. Wickner, R.B., H.K. Edskes, F. Shewmaker, and T. Nakayashiki, Prions of fungi: 
inherited structures and biological roles. Nature reviews microbiology, 2007. 5(8): 
p. 611-618. 
25. Liebman, S.W. and Y.O. Chernoff, Prions in yeast. Genetics, 2012. 191(4): p. 
1041-1072. 
26. Halfmann, R., D.F. Jarosz, S.K. Jones, A. Chang, A.K. Lancaster, and S. Lindquist, 
Prions are a common mechanism for phenotypic inheritance in wild yeasts. Nature, 
2012. 482(7385): p. 363-368. 
27. King, C.Y. and R. Diaz-Avalos, Protein-only transmission of three yeast prion 
strains. Nature, 2004. 428(6980): p. 319-23. 
28. Nilsson, M.R., Techniques to study amyloid fibril formation in vitro. Methods, 
2004. 34(1): p. 151-160. 
29. Hawe, A., M. Sutter, and W. Jiskoot, Extrinsic fluorescent dyes as tools for protein 
characterization. Pharm Res, 2008. 25(7): p. 1487-99. 
30. Pryor, N.E., M.A. Moss, and C.N. Hestekin, Unraveling the early events of 
amyloid-beta protein (Abeta) aggregation: techniques for the determination of 
Abeta aggregate size. Int J Mol Sci, 2012. 13(3): p. 3038-72. 
31. Yeh, V., J.M. Broering, A. Romanyuk, B. Chen, Y.O. Chernoff, and A.S. 
Bommarius, The Hofmeister effect on amyloid formation using yeast prion protein. 
Protein Science, 2010. 19(1): p. 47-56. 
32. Rubin, J., H. Khosravi, K.L. Bruce, M.E. Lydon, S.H. Behrens, Y.O. Chernoff, and 
A.S. Bommarius, Ion-specific effects on prion nucleation and strain formation. J 
Biol Chem, 2013. 288(42): p. 30300-8. 
33. Klement, K., K. Wieligmann, J. Meinhardt, P. Hortschansky, W. Richter, and M. 
Fandrich, Effect of different salt ions on the propensity of aggregation and on the 
structure of Alzheimer's abeta(1-40) amyloid fibrils. J Mol Biol, 2007. 373(5): p. 
1321-33. 
34. Tanaka, M., P. Chien, N. Naber, R. Cooke, and J.S. Weissman, Conformational 
variations in an infectious protein determine prion strain differences. Nature, 2004. 
428(6980): p. 323-328. 
 15 
35. Toyama, B.H., M.J. Kelly, J.D. Gross, and J.S. Weissman, The structural basis of 
yeast prion strain variants. Nature, 2007. 449(7159): p. 233-7. 
36. Sharma, J. and S.W. Liebman, Variant-specific prion interactions. Cell Logistics, 
2013. 3: p. e25698. 
37. Hofmeister, F., On the understanding of the effects of salts. Arch. Exp. Pathol. 
Pharmakol.(Leipzig), 1888. 24: p. 247-260. 
38. Kunz, W., J. Henle, and B.W. Ninham, ‘Zur Lehre von der Wirkung der Salze’ 
(about the science of the effect of salts): Franz Hofmeister's historical papers. 
Current Opinion in Colloid & Interface Science, 2004. 9(1): p. 19-37. 
39. Turton, D.A., J. Hunger, G. Hefter, R. Buchner, and K. Wynne, Glasslike behavior 
in aqueous electrolyte solutions. J Chem Phys, 2008. 128(16): p. 161102. 
40. Wachter, W., W. Kunz, R. Buchner, and G. Hefter, Is there an anionic Hofmeister 
effect on water dynamics? Dielectric spectroscopy of aqueous solutions of NaBr, 
NaI, NaNO3, NaClO4, and NaSCN. J Phys Chem A, 2005. 109(39): p. 8675-83. 
41. Tielrooij, K.J., N. Garcia-Araez, M. Bonn, and H.J. Bakker, Cooperativity in ion 
hydration. Science, 2010. 328(5981): p. 1006-9. 
42. Salis, A. and B.W. Ninham, Models and mechanisms of Hofmeister effects in 
electrolyte solutions, and colloid and protein systems revisited. Chem Soc Rev, 
2014. 43(21): p. 7358-77. 
43. Zhang, Y. and P.S. Cremer, Interactions between macromolecules and ions: the 
Hofmeister series. Current Opinion in Chemical Biology, 2006. 10(6): p. 658-663. 
44. Chien, P., J.S. Weissman, and A.H. DePace, Emerging principles of conformation-
based prion inheritance. Annual review of biochemistry, 2004. 73(1): p. 617-656. 
45. Tuite, M.F. and B.S. Cox, Propagation of yeast prions. Nature Reviews Molecular 
Cell Biology, 2003. 4(11): p. 878-890. 
46. Tuite, M.F. and B.S. Cox, The [ PSI+] prion of yeast: A problem of inheritance. 
Methods, 2006. 39(1): p. 9-22. 
47. Derkatch, I.L., Y.O. Chernoff, V.V. Kushnirov, S.G. Inge-Vechtomov, and S.W. 
Liebman, Genesis and variability of [PSI] prion factors in Saccharomyces 
cerevisiae. Genetics, 1996. 144(4): p. 1375-1386. 
48. Hardy, J.A. and G.A. Higgins, Alzheimer's disease: the amyloid cascade 
hypothesis. Science, 1992. 
49. Selkoe, D.J., The molecular pathology of Alzheimer's disease. Neuron, 1991. 6(4): 
p. 487-498. 
 16 
50. Selkoe, D.J., Cell biology of the amyloid beta-protein precursor and the mechanism 
of Alzheimer's disease. Annual review of cell biology, 1994. 10(1): p. 373-403. 
51. Walter, J., C. Kaether, H. Steiner, and C. Haass, The cell biology of Alzheimer's 
disease: uncovering the secrets of secretases. Current opinion in neurobiology, 
2001. 11(5): p. 585-590. 
52. Colvin, M.T., R. Silvers, Q.Z. Ni, T.V. Can, I. Sergeyev, M. Rosay, K.J. Donovan, 
B. Michael, J. Wall, S. Linse, and R.G. Griffin, Atomic Resolution Structure of 
Monomorphic Abeta42 Amyloid Fibrils. J Am Chem Soc, 2016. 138(30): p. 9663-
74. 
53. Walti, M.A., F. Ravotti, H. Arai, C.G. Glabe, J.S. Wall, A. Bockmann, P. Guntert, 
B.H. Meier, and R. Riek, Atomic-resolution structure of a disease-relevant 
Abeta(1-42) amyloid fibril. Proc Natl Acad Sci U S A, 2016. 113(34): p. E4976-84.
 17 
CHAPTER 2. CONTRIBUTION OF THE PRION PROTEIN 
SEQUENCE, STRAIN, AND ENVIRONMENT TO THE SPECIES 
BARRIER 
 This chapter is adapted from a research article bearing the same title published in 
the Journal of Biological Chemistry in November 2015. Kathryn L. Bruce, Buxin Chen, 
Stefka Gyoneva, Sven H. Behrens, Andreas S. Bommarius, and Yury O. Chernoff 
contributed to this work. 
2.1 Abstract 
 Amyloid propagation requires high levels of sequence specificity so that only 
molecules with very high sequence identity can form cross-𝛽𝛽-sheet structures of sufficient 
stringency for incorporation into the amyloid fibril. This sequence specificity presents a 
barrier to transmission of prions between two species with divergent sequences, termed a 
species barrier. Here, we study the relative effects of protein sequence, seed conformation, 
and environment on the species barrier strength and specificity for the yeast prion protein, 
Sup35p, from three closely related species of the Saccharomyces sensu stricto group, 
namely S. cerevisiae, S. bayanus and S. paradoxus. Through in vivo plasmid shuffle 
experiments we show that the major characteristics of the transmission barrier and 
conformational fidelity are determined by the protein sequence rather than cellular 
environment. In vitro data confirm that kinetics and structural preferences of aggregation 
of the S. paradoxus and S. bayanus proteins are influenced by anions in accordance to their 
positions in the Hofmeister series, as previously observed for S. cerevisiae. With the help 
of in vitro aggregation experiments, we show that the specificity of the species barrier is 
primarily affected by the sequence and the type of anion present during the formation of 
the initial seed, while anions present during the seeded aggregation process typically 
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influence aggregation kinetics rather than the specificity of prion conversion. Thus, our 
work shows that the protein sequence and the conformation variant (strain) of prion seed 
are the primary determinants of cross-species prion specificity both in vivo and in vitro. 
2.2 Introduction 
Amyloidogenic proteins form ordered self-seeding fibrous aggregates which are 
known to be associated with a variety of neurodegenerative diseases in humans and other 
mammals, such as Alzheimer’s disease, Parkinson’s disease, and prion diseases, including 
sheep scrapie, mad cow disease, elk and deer chronic wasting disease, and human 
Creutzfeldt-Jakob disease, kuru and fatal familial insomnia [1-5]. The amyloid/prion form 
of an amyloidogenic protein can convert the cellular form of a protein of the same or very 
similar amino acid sequence into an amyloid conformation, usually via cross-𝛽𝛽 interactions 
[6-9]. Transmissible amyloids, called prions, can spread the amyloid state between 
organisms. 
2.2.1 Species barrier 
Cross-species transmission of the prion state is impaired by sequence divergence 
within the prion proteins, resulting in a “species barrier” to transmission of a prion from 
one species to another [10]. However, the species barrier can be overcome in some species 
combinations. For example, bovine spongiform encephalopathy (BSE), which possibly 
originated from transmission of a scrapie prion from sheep to cattle, resulted in the widely 
known ‘mad cow’ disease epidemic which greatly affected the United Kingdom in the 
1990s [11, 12]. BSE was also found to be transmitted from cattle to humans, manifesting 
itself as a new variant of Creutzfeldt-Jakob disease, vCJD [13-16]. Therefore, 
 19 
understanding of the determinants of species barrier and cross-species prion transmission 
is crucial for preventing future outbreaks of prion diseases. However, the rules governing 
species barriers as well as effects of the physiological and environmental conditions on the 
barrier are poorly understood to date. In this work we, study the contribution of protein 
sequence, prion strain, and environment of cross-species transmission of a yeast prion 
protein from the Saccharomyces genus. 
2.2.2 Yeast Prion Sup35p 
Yeast prions are cytoplasmic elements heritable in a non-Mendelian fashion [17, 
18]. As many of them control phenotypically detectable traits, yeast prions provide a useful 
model for studying molecular basis of prion phenomena. One of the best studied yeast prion 
proteins is a translation termination factor Sup35. Prion formation by Sup35 causes 
translational readthrough (nonsense-suppression), a phenotypically detectable trait in 
specifically designed yeast strains [17, 18]. Previously, we [19, 20] and others [21] have 
reported observations of the species barrier and cross-species prion transmission between 
Sup35 proteins of three closely related yeast species - S. cerevisiae, S. paradoxus, and S. 
bayanus, containing Sup35p with high levels of sequence similarity. Sup35 protein can be 
divided into three segments: 1) N-terminal prion domain (Sup35N); 2) linker middle 
domain (Sup35M); and 3) functional C-terminal domain (Sup35C) responsible for 
translation termination and cell viability. Levels of similarity between the Sup35N 
fragments of the Sup35 proteins from the Sachharomyces sensu stricto are close to those 
observed among mammalian prion proteins [22, 23], which renders this system a useful 
model for studying species barrier. The Sup35N domain alone is difficult to express, as it 
is poorly soluble and aggregates too rapidly, whereas the addition of Sup35M domain 
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resolves all the above mentioned issues. Therefore, Sup35NM is widely used as a model 
protein for studying amyloid aggregation in vitro, and is shown to transmit prion properties 
to full-size Sup35 after transfection into the yeast cells [24, 25]. Amino acid similarities 
between the Sup35NM regions of the three different species are respectively 95% and 93% 
(S. cerevisiae / S. paradoxus combination), 85% and 78% (S. cerevisiae / S. bayanus 
combination), 85% and 79% (S. paradoxus / S. bayanus combination) [19, 20]. Sequence 
alignment of the N domains of Sup35 from the three yeast species is shown in Appendix 
A. Previous experiments performed by us with divergent Sup35 proteins (or proteins 
containing divergent or chimeric Sup35N domains) in S. cerevisiae cells have 
demonstrated that the prion species barrier depends on the level of divergence of Sup35N 
sequences, and that different sub-regions (modules) of Sup35N play a primary role in 
determining the barrier in different cross-species combinations [19, 20, 26]. A prion species 
barrier was also observed with divergent Sup35NM fragments in vitro [19].  
2.2.3 Prions “strains” or “variants” 
Prion proteins, including mammalian PrP and yeast Sup35 not only can fold into 
alternative prion and non-prion forms, but can also adopt multiple distinct amyloid 
conformations, known as “strains” or “variants” [17, 27-33]. Different strains are 
associated with distinct disease patterns in mammals and different stringencies of 
phenotypic effects in fungi (because of this, yeast prion strains could be termed “strong”, 
“intermediate”, “weak” etc.). Once formed, the prion strain is typically faithfully 
reproduced, although strain “mutations” may occur with a low frequency [34-38]. In both 
mammals and yeast, prion strain properties influence species barrier [26, 39]. For example, 
transmission of the specific “strong” prion strain from S. cerevisiae to S. paradoxus Sup35 
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prion domain (PrD) in S. cerevisiae cells is relatively efficient, while transmission of the 
specific “weak” prion strain in the same direction is rare [20]. Notably, underlying S. 
cerevisiae prion “strain” patterns were maintained during propagation through S. 
paradoxus protein, but irreversibly altered during propagation through S. bayanus protein, 
that could be detected as a “switch” of prion strain after reverse transmission back to the 
S. cerevisiae sequence [20]. This shows that not only efficiency of prion transmission but 
also fidelity of reproduction of prion conformation during transmission is controlled by the 
level of identity of interacting protein sequences. 
2.2.4 Ion-specific Effects on Sup35NM Prion Formation 
Previous work from our group has also demonstrated that the ion present in solution 
greatly influences not only processes such as deactivation of enzymes [40-42] but also the 
in vitro amyloid formation by S. cerevisiae Sup35NM, and that ion-specific effects are 
determined by their position in the Hofmeister series in the fashion of “inverse” Hofmeister 
effect. Specifically, strongly hydrated anions (kosmotropes) initiate nucleation quickly and 
promote rapid fiber elongation, while poorly hydrated anions (chaotropes) slow down the 
aggregation kinetics [43, 44]. A similar effect of kosmotropes has also been observed by 
another group for the mammalian prion protein, PrP [45]. Moreover, amyloid formation by 
Sup35NM in the presence of different anions resulted in the generation of a different 
spectrum of prion strains, with kosmotropes favoring the formation of “strong” strains 
(characterized by smaller aggregate size and higher frangibility and proliferation), and 
chaotropes favoring the formation of “weak” strains (characterized by larger aggregate size 
and lower frangibility and proliferation) [43, 44]. 
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In this work, we specifically address the contribution of the cellular composition and 
the conditions of the aggregation reaction to the specificity of prion transmission. In vitro 
aggregation experiments are performed to determine if anions of Hofmeister series 
influence cross-species specificity of prion transmission. Further, results of in vivo 
experiments are compared in the cells of different yeast species, to determine whether 
species specific patterns of intracellular environment influence the parameters of the prion 
species barrier. Our results are consistent with the notion that protein sequence and 
conformation remain the primary determinants of cell specificity, while environmental 
conditions influence specificity primarily via favoring the formation of different prion 
strains. 
2.3 Materials and Methods 
2.3.1 In vitro Techniques 
2.3.1.1 Expression and purification of Sup35NM  
Plasmid constructs containing the SUP35NM coding regions of different origins 
with the attached C-terminal His6 tags were generated as described previously [46] and 
expressed in E. coli host strain HMS174 (DE3) pLysS (Novagen) in order to produce the 
Sup35NM-(His6) proteins. The cell pellets were stored at −80°C until purification. 
Purification of Sup35NM proteins from E. coli was carried out as described previously 
[47]. The purified protein was precipitated using methanol at -20°C and stored at -80°C in 
80% methanol.  
2.3.1.2 Kinetic assays using thioflavin T 
 23 
Protein pellet stored at -80°C was collected by centrifugation. The supernatant was 
discarded and the protein was re-suspended in 8 M urea. Sup35NM was then concentrated 
by 10 kDa centrifugal filter and diluted 100 folds with PBS pH 7.4. The samples were 
boiled for about 10 min before starting the aggregation experiments to break down any 
preformed aggregates. 1 mM thioflavin T (ThT; Sigma Aldrich) solution was prepared 
fresh in PBS. Aggregation experiments were conducted in triplicates in a 96 well plate with 
final ThT and Sup35NM concentrations of 100 μM and 10 μM, respectively, and 
containing 0.4 M sodium salt. The seeded experiments contained 5% by volume of 
sonicated amyloid aggregates. Polymerization was carried out at 25°C in a 96-well plate 
with linear shaking at 18Hz in a BioTek Synergy H4 Hybrid Multi-Mode Microplate 
Reader (Winooski, VT). Fluorescence readings were taken every minute for about 16 hours 
using an excitation wavelength of 440 nm and emission wavelength of 480 nm.  
2.3.1.3 Preparation of amyloid seeds  
The respective sodium salt was added to Sup35NM, purified and prepared as 
described above, to a final concentration of 0.5 M salt and 10 μM protein in a micro-
centrifuge tube. The samples were allowed to rotate at 20 rpm at room temperature for 2 
days. After polymerization the amyloid samples were stored at -80 ⁰C until use. 
2.3.2 Yeast Cultivation and Genetic Techniques. 
2.3.2.1 Cultivation  
Standard yeast media and growth conditions were employed [48]. Yeast cultures 
were incubated at 30°C. Standard procedures [49] were used for [PSI+] detection, 
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characterization, and curing by GuHCl. All strains have an ade1-14 nonsense mutation in 
the ADE1 gene that contains a premature UGA stop codon, allowing detection of [psi-] and 
[PSI+] through the read-through or nonsense suppression assay [49]. 
2.3.2.2 Yeast transformation and transfection 
Standard techniques for yeast transformation were employed [48, 49]. For 
transfection with yeast extracts, cells of the [PSI+] donor strain were disrupted via a 
standard glass-bead lysis procedure, and resulting lysate was transfected into the 
spheroplasts of the [psi-] S. paradoxus strain GT1320-36A using a modified protocol 
described by Rubin et al. 2013 [44] and originally adapted from Tanaka et al. 2004 [24]. 
To prepare spheroplasts, the cell wall of a [psi-] recipient cell was fragmented with 
zymolase. An empty URA3 vector was co-transfected into the recipient cells as an indicator 
of that material has passed across the cell membrane (see Figure 2.1A).  
 
Figure 2.1 – Cross-species prion transfection. (A) Summary of the transfection 
procedure. (B) Cellular extract was transfected from either a strong or weak [PSI+] 
S. cerevisiae strain into a [psi-] S. paradoxus strain, expressing the Sup35 protein from 
S. cerevisiae. Representative [PSI+] S. paradoxus transfectants obtained from either 
the strong (left) or weak (right) [PSI+] donor strains are shown. Yeast cells were 
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grown on YPD (for color assay) and on –Ade medium (for suppression assay) at 30°C 
for 8 days.   
Transfectants were obtained on the medium counter-selecting against the Trp- 
donor strain (-Ura-Trp) in order to avoid contamination by donor cells. Both small and 
large colonies were observed on –Ura-Trp. Only large colonies contained the URA3 
plasmid, smaller colonies (from cells without the plasmid) resulted from background 
growth, possibly due to a low concentration of YPD present in the transfectant selection 
medium. The large Ura+ colonies were tested on –Ade medium to check for [PSI+] (see 
Figure 2.1B). Transfection of in vitro generated aggregates into S. cerevisiae strains GT797 
and GT987 was performed as previously described [44], with sonication in order to 
increase frequency of transfection, and using an empty plasmid with the LYS2 marker for 
selection of transfectants. 
2.3.2.3 Direct and reverse shuffle procedures  
The SUP35 genes of various origins were exchanged in the S. paradoxus strain 
(please refer Sharma et al. 2015 [50] for details), by using a plasmid shuffle procedure 
(Figure 2.2) performed as previously described for S. cerevisiae [19, 20], except that LYS2 
and URA3 markers were used on plasmids, instead of LEU2 and URA3. For direct shuffle, 
cells containing a SUP35SC LYS2 plasmid were transformed with a plasmid containing the 
SUP35 gene of the same or different origin, and URA3 marker, followed by loss of the 
original LYS2 plasmid (direct shuffle). From each individual [PSI+] transformant, only a 
single Ura+ Lys- colony was analyzed. To perform a reverse shuffle, cells obtained from 
direct shuffle and containing the SUP35SP URA3 plasmid were transformed with the 
SUP35SC LYS2 plasmid, and cured of the original URA3 plasmid. 
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Figure 2.2 – Plasmid shuffle scheme: Scheme of direct and reverse plasmid shuffle. 
“Sc” refers to SUP35 from S. cerevisiae. “PrDX” refers to SUP35 genes of various 
origins, or chimeric constructs. 
2.4 Results 
2.4.1  Amyloid Formation by Sup35NM from S. bayanus and S. paradoxus in the 
Presence of Different Salts along the Hofmeister Series 
To obtain materials for studying the cross-species prion transmission in vitro, we 
have first examined the unseeded amyloid formation of Sup35NMSb and Sup35NMSp in 
the presence of the salts (Figure 2.3, A and B), and compared results to our previous data 
for Sup35NMSc [44]. We have determined that the parameters of in vitro aggregation of 
Sup35NMSb and Sup35NMSp are influenced by anions of the Hofmeister series in the same 
way as previously observed for Sup35NMSc. For both proteins, the lag time of amyloid 
formation was shortened in the presence of sulfate (strong kosmotrope) and prolonged in 
the presence of perchlorate (strong chaotrope), compared to chloride (mild chaotrope). This 
establishes the generality of the inverse Hofmeister effect on the amyloid formation by 
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each of three Sup35NM proteins from the Saccharomyces species used in this work. 
 
Figure 2.3 – Aggregation profiles of Sup35NMSb and Sup35NMSp in the presence of 
0.4 M salts monitored by Thioflavin T fluorescence assay and phenotypic 
characterization of Sup35NMSb and Sup35NMSp prion strains. (A, B) Amyloid 
formation by Sup35NMSb (A) and Sup35NMSp (B) in the presence of 0.4M sulfate, 
chloride or perchlorate are presented to show the effect of Hofmeister ions on their 
aggregation. In the presence of a strong kosmotrope (sulfate), the lag times are short 
and elongation rates are fast. The opposite is true of aggregation in a chaotropic 
solution (perchlorate) while the aggregation plots show intermediate lag times and 
elongation rates in the presence of the mildly chaotropic chloride ions. (C, D) 
Distribution of weak, intermediate and strong [PSI+] colonies obtained after the 
transfection of the yeast strains GT987 (expressing Sup35Sb) and GT797 (expressing 
Sup35Sp) with Sup35NMSb (C) and Sup35NMSp (D) amyloids, respectively, obtained 
in the presence of sulfate, chloride or perchlorate salts. For both the proteins, 
amyloids formed in sulfate resulted in higher number of strong strains, which 
appeared white or faintly pink in color on YPD, than the amyloids formed in 
perchlorate which formed more weak strains appearing dark pink on YPD. Amyloids 
formed in chloride showed intermediate strain patterns to those formed in sulfate and 
perchlorate. 
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We have also determined if patterns of amyloids generated by Sup35NMSp and 
Sup35Sb in vitro are influenced by ionic composition. Amyloids generated by Sup35NMSp 
or Sup35NMSb in the presence of various salts were transfected into the [psi-] S. cerevisiae 
strain bearing either Sup35Sp or Sup35Sb protein instead of Sup35Sc. For both proteins, 
higher proportion of “weaker” [PSI+] isolates was detected after transfection with amyloids 
obtained in the presence of chloride or perchlorate, compared to amyloids obtained in the 
presence of sulfate (Figure 2.3, C and D). This confirms that a kosmotrope favours 
formation of “stronger” prion strains, while a chaotrope favours formation of “weaker” 
prion strains by Sup35NMSp and Sup35NMSb, similar to what has been described for 
Sup35NMSc [44]. 
2.4.2 Cross-Species Amyloid Seeding in the Presence of a Mild Chaotrope.  
Next, we have investigated the impact of sequence divergence on the species barrier 
between Sup35NM proteins from the three species. For this purpose, we studied cross-
species amyloid seeding in an “intermediate” environment, that is, in the presence of mild 
chaotrope (chloride) which is positioned between sulfate and perchlorate in the Hofmeister 
series. Amyloids used as seeds were also formed in the presence of chloride. The 
monomeric proteins (referred to as “monomers”) and the sonicated amyloid fibers (referred 
to as “seeds”) used as seeds for the aggregation assays, can be considered as in vitro 
analogues of the in vivo [psi-] recipients and [PSI+] donors, respectively (see section 2.4.5 
below). Our results (Figure 2.4) show that Sup35NMSc and Sup35NMSp are highly efficient 
in seeding each other in the presence of chloride, as we detect zero (or near zero) lag times 
for cross-seeding of Sup35NMSc with Sup35NMSp, and vice versa. In contrast, Sup35NMSb 
is less efficient in seeding the other two proteins or being seeded by them, and thus exhibits 
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a stronger species barrier (Figure 2.4). This generally agrees with in vivo data ([19, 20] and 
below), and can be explained by a higher degree of homology between the prion domains 
(PrDs) of Sup35NMSc and Sup35NMSp, and a lower degree of homology between the PrDs 
of any of these proteins and Sup35NMSb.  
 
Figure 2.4 – Lag time in hours for seeding experiments performed in 0.4 M sodium 
chloride. The seeds were formed in the presence of chloride salt. Homologous seeding 
is highly efficient with zero lag times. Sc/Sp combination results in zero or close to 
zero lag times. Larger lag times are observed in some cases involving Sb as a seed or 
monomer. 
Also, in accordance with previous reports, we observe an asymmetry in the species 
barrier [19, 20, 34, 51]. For example, seeding of Sup35NMSc monomer with the 
Sup35NMSb seeds results in a lag time of 2.22 hrs, while seeding of Sup35NMSb monomer 
with the Sup35NMSc seed shows essentially no lag time. A similar asymmetric effect is 
seen in the Sp/Sb heterologous seeding combination. 
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Notably, the asymmetry pattern observed in the presence of chloride was different 
from the asymmetry patterns observed in vivo, as well as in the previous in vitro data [19]. 
Those results uncovered a stronger barrier for the Sup35NMSb seeding with the 
Sup35NMSc seeds, rather than in the opposite direction. To further investigate this 
discrepancy, we have attempted both seed formation and cross-seeding in PBS, as in our 
previous work. Indeed, the asymmetry pattern observed in PBS resembled in vivo data and 
our previous in vitro results, rather than the asymmetry pattern observed in chloride (see 
Figure 2.5). Thus, the addition of chloride appears to reverse an asymmetry pattern of the 
species barrier, indicating that the ionic composition of the solution influences the barrier. 
To decipher the mechanism of this phenomenon, we have performed a more systematic 
study aimed at determining whether ionic composition acts via influencing “seed” 
properties or directly affects cross-seeding interactions. 
 
Figure 2.5 – Cross-seeding in the presence of a mild chaotrope. Lag time (A) and Slope 
in RFU/min (B) for unseeded and cross -seeding aggregation reactions between S. 
cerevisiae and S. bayanus in PBS. The seeds were also formed in PBS. Seeding 
Sup35NMSc monomer with Sup35NMSb seeds is more efficient (zero lag time and 
higher slope) than seeding Sup35NMSb monomer with Sup35NMSc seeds (non-zero 
lag time and lower slope). 
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2.4.3 Comparison of the Cross-Seeding Capabilities of Seeds Obtained in the Presence 
of Different Salts. 
First, we determined if cross-seeding is influenced by conditions in which a “seed” 
is generated. Hofmeister ions have been shown to affect both kinetics of amyloid 
aggregation and structural parameters of resulting aggregates, reflecting distinct protein 
conformations [43, 44]. Kosmotropic ions such as sulfate lead to faster kinetics and 
”stronger” strains and chaotropic ions such as perchlorate lead to slower kinetics and 
”weaker” strains [43, 44, 47, 52]. We have confirmed this for Sup35NMSp and Sup35NMSb 
(see above). As strain patterns influence cross-species prion conversion [20, 23], we have 
compared cross-seeding by seeds obtained in different salts. In all the reactions, we saw 
that amyloid seeds of the same protein formed in different salts have different lag times 
and slopes depending on the salt they are formed in (Figure 2.6 and Figure 2.7). 
Interestingly, seeds formed in sulfate do not always result in the shortest lag times, and 
seeds formed in perchlorate do not always lead to the longest lag times. Figure 2.8 shows 
the effect of salt present during seed formation on the species barrier in combinations 
Sup35NMSc/Sup35NMSb and Sup35NMSp/Sup35NMSb.  
In the case of Sup35NMSc/Sup35NMSb (Figure 2.8A), the seed obtained in chloride 
shows the shortest lag time in one of the combinations, while the seed obtained in 
perchlorate shows the shortest lag time in the other combinations. This agrees with our 
previous observation that for the Sup35Sc/Sup35Sb combination in vivo, the species barrier 
is more severe for the “strong” strain, compared to the “weak” strain. The combination 
Sup35NMSp/Sup35NMSb shows an even stronger trend in this direction, exhibiting the 
longest lag period for the sulfate-generated seeds in both reciprocal combinations (Figure 
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2.8B). Overall, our data demonstrate that salts of Hofmeister series influence species 
barriers via altering the structural parameters of the seed produced in the presence of the 
respective salt. 
 
Figure 2.6 – Lag times in hours for unseeded and seeded aggregation reactions. 
Homologous aggregation is more efficient than heterologous aggregation. 
Heterologous aggregation of Sup35NMSc and Sup35NMSp is very efficient with close 
to zero lag times while heterologous aggregation of Sup35Sb with the other two 
proteins is less efficient. Co-aggregation in the presence of sulfate leads to the shortest 
lag times and aggregation in perchlorate results in the longest lag times. 
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Figure 2.7 – Slope in RFU/min for unseeded and seeded aggregation reactions. 
Homologous aggregation is more efficient than heterologous aggregation. Co-
aggregation in the presence of sulfate leads to the highest slopes and aggregation in 
perchlorate results in the smallest slopes. 
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Figure 2.8 – Effect of seeding salt on heterologous co-aggregation Sc/Sb (A) and Sp/Sb 
(B). Amyloid seeds were formed in the presence of sulfate, chloride and perchlorate 
salts and aggregation was carried out in the presence of chloride salt. Salts present 
during seed formation affect co-aggregation kinetics as seen in a variation of the lag 
time. 
2.4.4 Comparison of Cross-Seeding Reactions Performed in the Presence of Different 
Salts 
To determine if the environment of the in vitro reaction influences the specificity 
of cross-seeding, we then investigated the effect of salts present in the aggregation medium 
on cross-seeding in the Sup35NMSb/Sup35NMSc and Sup35NMSb/Sup35NMSp 
combinations (Figure 2.9). Aggregation in sulfate, which is a strong kosmotrope, resulted 
in faster aggregation kinetics with shorter lag times and steeper slopes. On the other hand, 
aggregation in perchlorate, which is a strong chaotrope, resulted in longer lag times and 
smaller slopes. Aggregation kinetics in the slightly chaotropic chloride salt fell in between 
the kinetics observed for sulfate and perchlorate as the aggregation salts.  
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Figure 2.9 – Effect of aggregation salt on heterologous co-aggregation. (A) Sc 
monomer seeded with Sb amyloids seeds. (B) Sb monomer seeded with Sc amyloids 
seeds. (C) Sp monomer seeded with Sb amyloids seeds. (D) Sb monomer seeded with 
Sp amyloids seeds. Amyloid seeds were formed in the presence of sulfate, chloride and 
perchlorate salts. Irrespective of the salt-dependent seed, aggregation is the fastest in 
the presence of the strongly kosmotropic sulfate and slowest in the presence of the 
strongly chaotropic perchlorate. 
Despite numerical differences, this overall pattern was detected independently of 
the salt in which the initial seed was obtained (for more data and for the effect on slope as 
well as on the lag time, see Figure 2.6 and Figure 2.7). Hence, the salt in which the cross-
seeding reaction is performed has a strong and systematic influence on the kinetics of cross-
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seeding reaction but does not affect the specificity of reaction, in contrast to the salt in 
which the initial seed is generated. 
2.4.5 [PSI+] Transfection into Saccharomyces paradoxus Cells 
To transfer a S. cerevisiae prion into the cell of a different Saccharomyces species, 
was transfected the S. paradoxus strain bearing the SUP35Sc gene, with the extracts of 
[PSI+] S. cerevisiae cells (Figure 2.1A). The Ade+ colonies were identified among 
transfectants and shown to be curable of Ade+ phenotype by GuHCl, an agent eliminating 
yeast prions. Thus, we have shown that the prion formed in the S. cerevisiae donor species 
can be transfected into a different recipient species, S. paradoxus. Moreover, the major 
properties of specific prion variants were maintained independently of the cell environment 
(Figure 2.1B). For example, transfection with the cellular extract from the “strong” [PSI+] 
S. cerevisiae strain GT256-23C generated “strong” [PSI+] isolates in S. paradoxus, as can 
be seen from growth on –Ade medium, color in YPD medium (Figure 2.1B) and almost 
entire lack of spontaneous [PSI+] loss in mitotic divisions (only 3 out of 1624 colonies, 
obtained from 5 independent cultures, lost [PSI+]). In contrast, transfection with the cellular 
extract from the “weak” [PSI+] S. cerevisiae strain GT988-1A generated “weak” [PSI+] 
isolates in S. paradoxus (Figure 2.1B), Therefore, we were able to use the S. paradoxus 
cells containing the same “strong” [PSI+] strain that was previously studied in the S. 
cerevisiae cell environment for our shuffle experiments, that allowed a direct assessment 
of the effect of cell environment onto the species barrier. 
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2.4.6 Comparison of Cross-Species Prion Transmission in S. cerevisiae and S. paradoxus 
Cells 
To study the extent of influence of cell environment on the species barrier, cross-
species prion transmission of a “strong” Sup35Sc [PSI+] strain to S. paradoxus cells 
containing Sup35 proteins with PrD of different origin, or with a chimeric PrD was 
determined by using a plasmid shuffle procedure (Figure 2.2) and compared to previous 
results obtained in the S. cerevisiae cells [20]. Constructs with chimeric Sup35 PrDs were 
produced by reshuffling modules I (positions 1-33 in S. cerevisiae nomenclature), II 
(positions 34-96) and III (positions 97-123) in all possible combinations as described 
earlier [20]. Modules I and II roughly correspond to the QN-rich stretch and region of 
oligopeptide repeats, respectively. These are sub-regions of Sup35 PrD that were 
previously shown to influence the specificity and fidelity of cross-species prion 
transmission [20]. Results and comparison to the previous data are shown in Figure 2.10A.  
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Figure 2.10 – Comparison of direct cross-species prion transmission in the S. 
cerevisiae and S. paradoxus cell environments. (A) Frequency of [PSI+] transmission 
from S. cerevisiae Sup35 proteins to the proteins with divergent or chimeric prion 
domains (as indicated) is shown. Data obtained from the S. cerevisiae cell environment 
(shown in blue) were previously published in Chen et al, 2010. Numerals I, II, and III 
refer to the exchangeable modules of the PrD. “Sc”, “Sp”, and “Sb” refer to S. 
cerevisiae, S. paradoxus, and S. bayanus, respectively. (B) Phenotypes of [PSI+] 
produced from direct transmission in S. paradoxus. Numerals I, II, and III refer to 
the exchangeable modules of the PrD. “Sc”, “Sp”, and “Sb” refer to S. cerevisiae, S. 
paradoxus, and S. bayanus, respectively. YPD (top) and –Ade (bottom) plates were 
photographed after 8 days. 
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Overall, similar patterns of transmission were observed in both S. cerevisiae and S. 
paradoxus cells, although some numerical differences were found. In both cases, the 
strongest barrier was detected between the S. cerevisiae and S. bayanus PrDs (in the S. 
paradoxus cells, no transmission was detected for this combination at all). By contrast, 
there was only a slight decrease in prion transmission from Sup35Sc to proteins with S. 
paradoxus PrD or its QN-rich stretch (module I). Previously described constructs with 
chimeric PrDs [20] were used to determine the roles of various regions of Sup35 in the 
species barrier. Similar to the experiments in S. cerevisiae cells, the region of oligopeptide 
repeats (module II) was a primary determinant of species-specificity of prion conversion 
in the combination of S. cerevisiae and S. bayanus. Notably, transmission of the prion state 
from Sup35Sc to any protein with the QN-rich stretch (module I) and/or the region of 
oligopeptide repeats (module II) coming from the species other than S. cerevisiae resulted 
in the appearance of a phenotypically weaker prion (Figure 2.10B), as previously observed 
in S. cerevisiae [20].  
In further experiments, prions generated by transmission from Sup35Sc to proteins 
with divergent or chimeric PrDs were transmitted back to Sup35Sc by using reverse shuffle 
(Figure 2.11).  
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Figure 2.11 – Comparison of reverse cross-species prion transmission in S. cerevisiae 
and S. paradoxus. Frequencies of [PSI+] transmission from the divergent or chimeric 
prion domains (as indicated) to the S. cerevisiae protein are shown. Designations are 
the same as in Figure 2.10. Notably, the reverse shuffle constructs containing the S. 
paradoxus PrD or its module I restored the original strong [PSI+] variant. In contrast, 
reverse shuffle from constructs containing module II of S. bayanus produced weak 
[PSI+] variants. 
In most cases, results followed the same pattern as previously detected in S. 
cerevisiae [20]. As in S. cerevisiae, reverse transmission of prion state to Sup35Sc from the 
constructs containing the module II of S. bayanus was high in S. paradoxus, confirming 
the asymmetry of the species barrier in the S. cerevisiae – S. bayanus combination. On the 
other hand, while proteins containing S. paradoxus PrD or at least its module I transmitted 
the [PSI+] state to Sup35Sc efficiently, a noticeable decrease was detected in S. paradoxus, 
compared to the S. cerevisiae cells.  
For most combinations, the “strong” [PSI+] phenotype has been restored after reverse 
transmission to Sup35Sc, confirming that to the extent detectable by the resolution of our 
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approach, prion “weakening” during its propagation by a divergent or chimeric protein was 
due to changes in its phenotypic expression rather than in the molecular “properties” of 
prion strain. However, the Sup35Sc prion strain became “weak” after the reverse 
transmission from the protein containing at least module II from S. bayanus (Figure 2.12). 
Therefore, the underlying properties of the prion variant were irreversibly changed in this 
combination, once again confirming previous observations made in S. cerevisiae cells [20].  
 
Figure 2.12 – Reproduction and switch of prion variants in cross-species transmission 
in the S. paradoxus cell environment on reverse shuffle. Representatives of direct 
shuffle experiment where [PSI+] isolates obtained from a strong S. cerevisiae prion 
variant in the S. paradoxus cell environment went through direct shuffle to the control 
S. cerevisiae Sup35 protein or chimeric proteins with either S. paradoxus PrD or S. 
bayanus Module II PrDs, followed by reverse shuffle back to S. cerevisiae Sup35. 
(Top: YPD medium; Bottom: -Ade medium.) 
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Overall, our data show that the major rules of a transmission barrier, applying to both 
efficiency of prion transmission and fidelity of the reproduction of prion “strain” patterns 
by a divergent protein, are generally invariant in S. cerevisiae and S. paradoxus host cells, 
even though some quantitative differences were detected.  
2.5 Discussion 
We have previously reported that anions of the Hofmeister series influence kinetics 
and strain preference during in vitro amyloid formation by Sup35NMSc [44, 47], and now 
we show that Sup35NM proteins from the other species of the Saccharomyces sensu stricto 
group, Sup35NMSb and Sup35NMSp, also respond to the presence of kosmotropic or 
chaotropic ions in the same way as Sup35NMSc. We have confirmed previous data by 
showing that in vitro, in agreement with previous research, the more similar Sc/Sp proteins 
exhibit a relatively low barrier in the transmission of prion state, while the more divergent 
Sb protein shows a high barrier with the other two proteins [19]. We also performed 
systematic studies of the effects of the Hofmeister series anions on cross-species prion 
transmission. Overall, our data show that the salt present during amyloid formation can 
alter parameters of the species barrier. The most plausible explanation for this result is that 
the salts present during seed formation determine the seed conformation, which in turn 
influences the efficiency of conformational adaptation of a new monomer to the preformed 
nuclei provided by this seed. This agrees with our previous in vivo data showing that the 
prion strain pattern controls the specificity of transmission of the prion state to the newly 
immobilized protein [20]. In contrast, salts present during the process of cross-seeding 
exhibit a strong and systematic influence on the kinetics of cross-species aggregation in 
 43 
accordance with the inverse Hofmeister trend that has been previously reported for 
homologous aggregation [44], but they do not alter the transmission specificity. 
Interestingly, we observed that the seeds formed in chloride are more efficient in promoting 
both homologous and cross-species aggregation than the seeds formed in sulfate or 
perchlorate (Figure 2.6 and Figure 2.7). We hypothesize that this might be because seeded 
nucleation in chloride produces a very diverse mix of various prion strains. This diversity 
helps in providing a pool of seed conformations some of which more amenable for the 
monomer to template onto. Thus, there always exists a fraction of strains which can act as 
highly efficient templates in any given conditions. By contrast, aggregation in the presence 
of either highly kosmotropic (e. g. sulfate) or highly chaotropic (e.g. perchlorate) salt 
exhibits a more pronounced bias toward one particular strain, thus the type of the strain 
“pre-adopted” to the changed environment may not exist for certain conditions.   
Previous work by the Weissman group has shown that temperature can be used to 
affect the specificity of the species barrier between Saccharomyces cerevisiae and Candida 
albicans. Tanaka et al. [24] observed that when Sup35NMSc is aggregated at low (4ºC) 
temperature, more “promiscuous” aggregates with a stronger phenotype and higher seeding 
capabilities can be generated, compared to aggregates produced at high (37ºC) temperature. 
Tanaka et al. [53] had shown that the seeds of the S. cerevisiae Sup35NM protein formed 
at different temperatures show variable ability to cross-seed the Sup35NM protein from 
Candida albicans. Chien et al. [54] had shown that polymerization of a chimeric protein, 
combining the regions from the Sup35 prion domains of both S. cerevisiae and C. albicans 
can produce distinct prion strains with different seeding specificities, depending on 
temperature. These results agree with our observations that the differences in ionic 
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composition influence species barrier via promoting formation of different strains. 
However, our work represents the first systematic comparison of the effects of aggregation 
conditions at the stages of initial aggregate formation and cross-species seeding. Our data 
confirm that protein sequence and conformation play a central role in determining 
specificity of prion transmission, and show that external factors influence transmission 
specificity primarily via altering the nature of the initial seed, whereas the conditions of 
the actual cross-seeding reaction itself have an impact only on the kinetics of the process. 
Further, by constructing a unique set of S. paradoxus strains allowing for prion 
detection and using the transfection protocol, we were able to obtain the S. cerevisiae and 
S. paradoxus cultures with one and the same “strain” of prion that helped us differentiate 
the effects of prion protein properties and intracellular environment on cross-species prion 
conversion. Our data show that both transmission barrier and conformational fidelity in 
vivo are primarily determined by the protein itself rather than by the environment. Thus, 
differences between the S. cerevisiae and S. paradoxus intracellular environments do not 
affect major rules of [PSI+] transmission, although they might influence the quantitative 
characteristics of the process.  
2.6 Conclusions and future work 
Chapter 2 presents a detailed systematic study of species barrier in closely related species 
of the Saccharomyces sensu stricto group and demonstrates that the most important factor 
in determining the efficiency of cross-species transmission is the similarity in the 
sequences of the donor and recipient proteins both in vivo and in vitro, followed by the type 
of prion strain, while the effect of the environment is very systematic and only determines 
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the efficiency of co-transmission. Since the sequence similarity and identity levels of this 
system are similar to that of mammalian prion proteins, cross-species transmission of 
mammalian prion proteins can also be expected to behave in a similar fashion. This 
suggests that cross-species transmission is more likely between mammalian prion proteins 
which share high levels of sequence similarity and identity with each other. On the other 
hand, certain prion strains can possess a conformation which makes them more infectious 
and easily transmissible perhaps due to ease of conformational templating and addition of 
monomer onto their active surface. And finally, we can expect the environmental 
conditions that promote amyloid formation to promote cross-seeding or cross-species 
transmission while conditions which obstruct amyloid aggregation to hinder transmission 
of prions between different species. 
An extension of this work would be to investigate if cross-transfection of aggregates 
produced in vitro in the presence of different salts results in similar patterns of transmission 
as seen in the in vitro cross-seeding experiments. For example, Sup35NMSc seeds formed 
in the presence of a particular salt can be transfected into S. bayanus and S. paradoxus and 
the efficiency of transmission can be determined. Such a study can provide a direct 
comparison between in vitro and in vivo cross seeding indicating how well the in vitro 
cross-seeding experiments mirror cross-transmission of a prion in vivo. 
Further, it will also be interesting to study the relative contribution of the environment and 
the seed strain on the final conformation of the aggregates formed. To do so, aggregates 
formed in the presence of a particular salt for example sodium sulfate can be used to seed 
Sup35NM in the presence of a salt of the opposite effect like sodium perchlorate and the 
structure of the final aggregate formed can be studied by TEM and/or AFM. Similarly, a 
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combination of seeding and aggregation salts can be used to further understand the relative 
influence of the seeding conditions and the environment on the conformation of the 
resulting aggregate and how faithfully the amyloid template is reproduced when the 
conditions of aggregation are altered. 
It is interesting to note that Tanaka et. al. [24] had observed that Sup35NM strains with a 
‘strong’ phenotype were formed at a low temperature (4ºC) while strains with a ‘weak’ 
phenotype were formed at a high temperature (37ºC). The aggregates formed at 4ºC 
showed lower thermal stability than the ones formed at 37ºC. Although the aggregation 
kinetics and the structure of the fibers formed were not determined in this work, we and 
others have observed that amyloid aggregation is faster at higher temperatures and slower 
at low temperatures [55]. So, interestingly while the aggregates formed at 4ºC have lower 
stability and result in strong phenotypes on transfection just like the ones formed in the 
presence of kosmotropes, the aggregation kinetics in the two cases are very different.  
Therefore, the phenotype on transfection and possibly the amyloid structure may not 
depend directly on the aggregation kinetics. This may be explained by the fact that while 
high temperature and the presence of kosmotropes both result in faster kinetics the driving 
force behind each effect is different. Crowding and depletion interactions due to the 
presence of kosmotropes result in bringing the species in solution closer to each other and 
hence, result in faster aggregation. On the other hand, it is the increase in the average 
kinetic energy and the number of collisions that overcome the activation energy barrier 
between the species in solution caused by a rise in temperature, which results in faster 
kinetics. This suggests that perhaps kinetics does not dictate amyloid strain conformation. 
It would be fruitful to look at the effect of other environmental conditions to further 
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evaluate the role of kinetics in strain formation. For example, the effect of agitation or other 
co-solutes on aggregation kinetics, stability, structure, and phenotype of the amyloid strains 
formed can be studied and compared to the effect of ions and temperature. 
Finally, we can also investigate if the effect of ions on the surface tension of water results 
in the observed effect on amyloid aggregation or if it is some other ion-specific property. 
In this work, we have shown that the anion present during aggregation affects the kinetics 
of seeded aggregation similar to unseeded aggregation. To test if this is caused by changes 
in surface tension or some other ion-specific property, other additives which affect surface 
tension in a similar fashion could be added as co-solutes. For example, osmolytes such as 
sugars (e.g. sucrose) increase the surface tension of water by exerting a crowing effect 
similar to kosmotropes and their presence as a co-solute can be expected to result in faster 
aggregation kinetics. On the other hand, surfactants such as SDS reduce the surface tension 
like chaotropes and can be expected to result in slower aggregation kinetics. Hence, 
crowding agents and surfactants can be added as co-solutes to unseeded and seeded 
reactions and their effect on the kinetics of aggregation can be investigated. 
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CHAPTER 3. ION-SPECIFIC EFFECTS ON AGGREGATION OF 
AMYLOID BETA-42 AND SUP35NM 
3.1 Abstract 
The amyloid aggregation process is influenced by the presence of co-solutes in vitro. 
Ion-specific effects on the stability, solubility, and precipitation of proteins can generally 
be correlated to their position in the Hofmeister series. Here, we have studied the effect of 
anions on fiber formation by Amyloid beta42 (Aβ42) and Sup35NM at pH above and below 
their isoelectric points. We find interesting differences in the aggregation kinetics of Aβ42 
and Sup35NM in the presence of ions. Further, the electrophoretic mobilities of Aβ42 and 
Sup35NM were measured in the presence of anions at pH above and below the isoelectric 
points to understand how the respective anions interact with these proteins when they are 
positively or negatively charged. We find that while ion-protein interactions generally 
follow expectations as per their position in the Hofmeister series, there are qualitative 
differences in the aggregation behaviour of Aβ42 and Sup35NM. These differences may be 
explained by their widely different biochemical and biophysical properties and point 
towards a difference in their mechanisms of aggregation. 
3.2 Introduction 
The amyloid aggregation process is dependent on two main factors, namely, the 
primary sequence of the protein, and environmental conditions. For the same protein 
sequence, changes in temperature, pH, solvent composition, agitation etc. have a clear 
impact on the aggregation kinetics and the structure of the fibers formed [1-4]. The fiber 
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morphology in turn determines strain properties which govern disease patterns in 
mammals. Therefore, an investigation of the effect of environmental factors on aggregation 
kinetics can help in understanding the root cause of differences in disease progression. 
3.2.1 Ion-specific effects 
Ions can be classified on the basis of their effect on protein solubility and 
conformation. The Hofmeister series, originally developed by the German scientist Franz 
Hofmeister in the late 1800s from observations on the ability of ions to precipitate hen egg 
white lysozyme, serves as a guide to the effect of ions on protein stability [5]. The ions in 
the series are arranged according to their ability to salt out (precipitate) and salt in 
(solubilize) most proteins. Ions which are larger in size, weakly hydrated, less polarized, 
decrease surface tension, and increase protein solubility lie towards one end of the series. 
These ions were originally proposed to interfere with the hydrogen-bonding of water and 
were termed as ‘chaotropes’ or ‘water structure breakers’. On the other hand, the smaller, 
strongly hydrated ions which increase surface tension and decrease protein solubility, 
favoring the most compact conformation lie towards the other end of the series and were 
called ‘kosmotropes’ or ‘water structure makers’. The presence of ions also affects the 
viscosity of bulk water and the position of ions in the Hofmeister series has also been shown 
to correlate with the Jones-Dole viscosity B coefficient in the following equation. 
 𝜂𝜂
𝜂𝜂𝑜𝑜
= 1 + 𝐴𝐴𝑐𝑐1 2� + 𝐵𝐵𝑐𝑐 (1) 
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Here, η is the viscosity of aqueous solution of ions, ηo is the viscosity of water, c is 
concentration of the ion, A is a term to account for electrostatic effects and B is a measure 
of the strength of ion-water interactions. B is generally negative for the weakly hydrated 
chaotropes which result in reduction in viscosity with increase in concentration and is 
positive for the strongly hydrated kosmotropes which result in increase in viscosity with 
increase in concentration. 
3.2.2 Studies on the effect of ions on amyloid formation 
Previous work from our group has shown that sodium salts of different anions can 
alter the aggregation kinetics and the structure of the amyloid aggregates formed by the 
prion domain containing NM fragment of Sup35 proteins from Saccharomyces cerevisiae 
at a pH of 7.4 [1, 2]. The effect of the anions on Sup35NM aggregation kinetics and 
amyloid structure correlates very well with their position in the Hofmeister series. In a 
separate study on species barrier we have also shown that anions can be used to form seed 
‘strains’ or ‘variants’ with different transmissibility across closely related species of the 
Saccharomyces sensu stricto group [6]. The effect of ions on fiber nucleation and 
elongation, and conformation has been studied for a few other amyloidogenic proteins such 
as amylin, α-synuclein, β2-microglobulin, mouse prion protein, Aβ40, etc. [3, 7-10]. 
However, a clear and comprehensive understanding of these effects keeping in 
consideration the charge on the protein at the experimental conditions has not been 
presented. Moreover, a careful comparative study of these effects on different proteins has 
not been done. 
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In this work, we have investigated and compared the effect of anions of the 
Hofmeister series on the aggregation kinetics of Sup35NM and Aβ42. Aβ42 is a 42 amino 
acid-long peptide formed by the proteolytic cleavage of amyloid precursor protein (APP), 
and is considered to be the primary protein associated with Alzheimer’s disease. It forms 
fibrillar aggregates which associate together resulting in the formation of amyloid plaques 
in the central nervous system of the patient and lead to neuronal cell death and 
degeneration. Recent work by two separate groups on demonstrating the structure of Aβ42 
fibers has shown that in the fibrillar form the peptide buries its hydrophobic residues in the 
core of symmetrical dimers that are stacked perpendicular to the axis of the fiber [11, 12]. 
Sup35NM on the other hand has been shown to form fibers with a single molecule per layer 
primarily through interactions of glutamine and asparagine residues in the beta sheet rich 
prion domain of the protein [13]. Both the proteins have been shown to form aggregates 
composed of parallel in-register beta sheets [13-15]. 
Ions play a crucial role in many biological functions. Ion-specific effects are usually 
found to be more pronounced for anions than cations which are generally excluded from 
protein-water interface and exhibit less pronounced Hofmeister effects. Amongst anions, 
chloride ions are universally present in living organisms and other anions like phosphate, 
iodide, fluoride, acetate, citrate, biocarbonate, nitrate, etc. can also be present in different 
compartments of a cell. Cells, organelles, and body fluids can also have different pH 
values. While ionic concentration and pH are tightly regulated in the body to ensure proper 
biological functioning, any variations in the localized ionic concentration and pH can 
significantly affect the stability of proteins and may promote disordered aggregation as 
well as amyloid formation. Therefore, an understanding of the effect of ion concentration 
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and pH on protein stability and aggregation can shed light on the causal factors of amyloid 
formation in living organisms. 
Here, we have studied the aggregation of Sup35NM and Aβ42 in the presence of 
sodium salts at pH of 3.2, 4.5 and, 7.4. The isoelectric points (pI) of Sup35NM and Aβ42 
are around 5.3. We observe some similarities in the effect of ions on the fibrillation kinetics 
of the two proteins, pointing to the universal nature of the effect of ions, as well as some 
differences in the aggregation behavior of these two proteins which can be correlated to 
the biophysical properties of these proteins and points to differences in the aggregation 
mechanisms of the two proteins. 
3.3 Material and Methods 
3.3.1 Expression and purification of Sup35NM 
E. coli host strain HMS174 (DE3) pLysS (Novagen) was transformed with pET21b 
vector containing the NM domain coding region of Sup35p from Saccharomyces cerevisiae 
with an attached C-terminal His6 tag [16]. Sup35NM was expressed and purified as 
described previously [2]. Briefly, the cells were transformed with the cloning vector, 
protein expression was induced using isopropyl β-D-1-thiogalactopyranoside (IPTG), and 
the cells were harvested after about 4 hours of induction at 37°C. The cell pellets were 
stored at −80°C until purification and the protein was purified by Ni-NTA His-tag affinity 
purification under denaturing conditions. The purified protein was precipitated using cold 
methanol at -20°C, the protein pellet was collected by centrifugation and washed with cold 
methanol, and finally stored at -80°C in 80% methanol. 
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3.3.2 Expression and purification of recombinant Aβ42 
Gene encoding Aβ42 peptide was cloned into pET28 vector using restriction enzymes, NcoI 
and Xho1, and primers (5’-GCGCGCGC CC ATG GAT GCA GAA TTC CGA -3’ 
(forward) and 5’-GCGC CTC GAG TTA CGC TAT GAC AAC ACC-3’ (reverse)). E. coli 
host strain BL21 STAR (DE3) (Invitrogen) was transformed with pET28 vector containing 
the gene encoding Aβ42. Aβ42 was purified by a modified protocol adapted from Walsh et 
al. 2009 [17]. Anion exchange chromatography was performed using Q-Sepharose resin 
(Sigma Aldrich). Fractions containing pure peptide were pooled together and concentrated 
using a 3kDa centrifugal filter (EMD Millipore) and buffer exchanged into 2mM NaOH, 
lyophilized, and stored at −80°C.  
3.3.3 Fibrillation assays using Thioflavin T 
Sup35NM protein pellet stored in 80% methanol at -80°C was collected by 
centrifugation. The supernatant was discarded and the protein was re-suspended in 8 M 
urea. Sup35NM was then concentrated by 3 kDa centrifugal filter (EMD Millipore) and 
diluted 100 folds into the buffer of choice. The samples were boiled for about 10 min before 
starting the aggregation experiments to break down any preformed aggregates. A stock 
solution of 1 mM thioflavin T (ThT; Sigma Aldrich) was prepared fresh in the same buffer.  
Lyophilized Aβ42 was resuspended in HPLC grade water. The peptide was then 
filtered through a 30kDa centrifugal filter to obtain the low molecular weight fractions and 
diluted with 10X buffer to make the final concentration of the peptide 20 μM. 
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Aggregation experiments were conducted in triplicates in a 96 well plate with final 
ThT, Sup35NM, and Aβ42 concentrations of 10 μM, 10 μM, and 20 μM, respectively, 
containing 0.1M, 0.3M, and 0.5 M sodium salt. Fibrillation assays were carried out at 37°C 
in a 96-well plate with orbital shaking at 307 rpm (5mm amplitude) in a BioTek Synergy 
H1 Multi-Mode Microplate Reader. Fluorescence readings were recorded every 10 minutes 
using an excitation wavelength of 440 nm and emission wavelength of 485 nm.  
3.3.4 Electrophoretic mobility measurements 
Electrophoretic mobility values of Sup35NM and Aβ42 at concentrations of 10 μM 
and 20 μM, respectively, were measured in solutions at pH of 3.2, 4.5, and 7.4 containing 
0.1M, 0.3M and 0.5M sodium salts using Malvern Zetasizer Nano ZS. 
3.4 Results 
3.4.1 Fibril formation by Sup35NM and Aβ42 at pH above pI 
Since, the isoelectric points of both Sup35NM and Aβ42 are around 5.3, at pH = 7.4, 
both the proteins are positively charged. We observe that the effect of ions on the 
fibrillation of Sup35NM at pH 7.4 correlates with the position of the ions along the 
Hofmeister series with kosmotropic ions such as SO42-, IO3-, and F- making the aggregation 
faster and chaotropic ions such as Cl-, Br- and ClO4- slowing down the aggregation as the 
salt concentration is increased (Figure 3.1). This agrees with our previous reports on the 
effect of ions on the aggregation of Sup35NM at 25ºC [1, 2]. 
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Figure 3.1 – Fibrillation of Sup35NM at pH 7.4 in the presence of sodium salts of SO42-
, IO3-, F-, Cl-, Br-, and ClO4- at 37ºC. The fiber fraction was determined from relative 
fluorescence units (RFU) measured at an excitation wavelength of 440nm and 
emission wavelength of 485nm. 
 61 
On the other hand, we see that the presence of both kosmotropic and chaotropic 
anions promotes faster fibrillation of Aβ42 at pH 7.4 (Figure 3.2). While we expect the 
effect of kosmotropes to remain the same, our observation of the effect of chaotropes on 
Aβ42 aggregation is interesting. Here, we see that increasing concentration of chaotropes 
result in faster aggregation of Aβ42. This is opposite to the effect of increasing 
concentrations of chaotropes on aggregation of Sup35NM where we had seen that as the 
concentration of chaotropes was increased the aggregation was hindered (Figure 3.1). 
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Figure 3.2 – Fibrillation of Aβ42 at pH 7.4 in the presence of sodium salts of SO42-, IO3-
, F-, Cl-, Br-, and ClO4- at 37ºC 
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While increasing the concentration of chaotropic ions favored faster aggregation 
for Aβ42, however, similar to Sup35NM, the relative effect of anions (at the same  
concentration) on the kinetics of aggregation of Aβ42 still correlated with their position in 
the Hofmeister series (Figure 3.1 and Figure 3.2). For example, at a concentration of 0.5M 
the most kosmotropic SO42- was the most effective in promoting aggregation while the 
most chaotropic ClO4- was the least effective for Sup35NM and Aβ42 both (Figure 3.3 and 
Figure 3.4). 
 
Figure 3.3 – Fibrillation of Sup35NM at pH 7.4 in the presence of 0.5M salt 
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Figure 3.4 – Fibrillation of Aβ42 at pH 7.4 in the presence of 0.5M salt 
3.4.2 Electrophoretic mobility of Sup35NM and Aβ42 at pH above pI 
Next we performed electrophoretic mobility measurements in the presence of ions 
to understand how they interact with Sup35NM and Aβ42. We observe that as the 
concentration of the ions is increased charge screening increases resulting in an overall 
reduction in electrophoretic mobility. However, chaotropes are able to adsorb to both 
Sup35NM and Aβ42 ions in spite of the net negative charge on both proteins at pH 7.4. This 
results in the electrophoretic mobilities in the presence of chaotropes being more negative 
than in the presence of kosmotropes (see Figure 3.4 and Figure 3.5). Mobility 
measurements in the presence of SO42- are excluded from the reported data since SO42- 
being a divalent ion offers stronger shielding than monovalent ions, and for the same ionic 
strength of Na2SO4, the concentration of SO42- is different, making a direct comparison of 
mobilities in Na2SO4 and mobilities in sodium salts of monovalent ions infeasible. 
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Figure 3.5 – Electrophoretic mobilities of Sup35NM at pH 7.4 in the presence of 


































Figure 3.6 – Electrophoretic mobilities of Aβ42 at pH 7.4 in the presence of sodium 
salts of monovalent anions 
 
3.4.3 Fibril formation by Sup35NM and Aβ42 at pH below pI 
Further, we investigated the effect of anions on the aggregation kinetics of Aβ42 and 
Sup35NM when the charge on the proteins is reversed. In order to do this, we performed 


























Due to incomplete dissociation of most of the kosmotropic ions in the acidic pH range we 
are limited to just SO42- and IO3- at pH 3.2 and SO42-, IO3- and H2PO4- at pH 4.5. At a pH 
of 3.2, we see an inversion in the effect of chaotropes on Sup35NM, while the effect of 
kosmotropic ions which act by exerting a depletion force is the same. At this pH, chaotropic 
ions which can interact with specific regions in a polypetide chain, result in more effective 
charge screening and neutralization, and promote fast fibril formation by Sup35NM.  
The effect of both kosmotropes and chaotropes on fibril formation by Aβ42 at pH 
3.2 is similar to Sup35NM  (see Figure 3.6 and Figure 3.7). This reversal of the Hofmeister 
effect for chatropes on inversion of the net charge on the molecules has been reported for 
colloidal systems and globular proteins [18-23] 
Next, we investigated the consequence of  reduction in the net charge on Sup35NM 
and Aβ42 on the effect of ions on their aggregation. While the effect of kosmotropes on 
both Sup35NM and Aβ42 remains the same at pH 4.5,  the strong chaotropes (Br- and ClO4-
) show a partial reversal in their fibrillation promoting effect at  pH 4.5. After a threshold 
concentration the aggregation becomes slower as the concentration of these ions which 
adsorb strongly to the proteins is increased (Figure 3.8). Interestingly no such reversal is 
seen for Aβ42 (Figure 3.9).  
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Figure 3.7 – Fibrillation of Sup35NM at pH 3.2 in the presence of sodium salts of  
SO42-, IO3-, Cl-, Br-, and ClO4- at 37ºC 
 69 
 
Figure 3.8 – Fibrillation of Aβ42 at pH 3.2 in the presence of sodium salts of SO42-, IO3-
, Cl-, Br-, and ClO4- at 37ºC 
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Figure 3.9 – Fibrillation of Sup35NM at pH 4.5 in the presence of sodium salts of SO42-
, IO3-, H2PO4-, Cl-, Br-, and ClO4- at 37ºC 
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Figure 3.10 – Fibrillation of Aβ42 at pH 4.5 in the presence of sodium salts of SO42-, 
IO3-, H2PO4-, Cl-, Br-, and ClO4- at 37ºC 
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3.4.4 Electrophoretic mobility of Sup35NM and Aβ42 at pH below pI 
Next, we measured the electrophoretic mobilities of Sup35NM and Aβ42 at pH 3.2 
and 4.5, where both proteins are positively charged and anions act as counter-ions. Again, 
we see that as the concentration of the ions is increased charge screening increases resulting 
in an overall reduction in electrophoretic mobility. Additionally, similar to pH 7.4, the 
chaotropic anions are able to adsorb better to both Sup35NM and Aβ42 than kosmotropes. 
This results in greater reduction in the effective charge on the proteins in the presence of 
chaotropes and mobilities being smaller in the presence of chaatropes at pH 3.2 and 4.5 
(see Figure 3.10, Figure 3.12, Figure 3.11, and Figure 3.13).  At pH 4.5, where the net 
charge on the protein is less we see that increasing the concentration of Br- and ClO4- results 
in a reversal in the sign of the mobility and, hence, the charge on Sup35NM. Further 
increase in the ion concentration adds more negative charges on the protein due to 
adsorption of more ions resulting in increase in the negative mobilities at higher 
concentrations of the strong chaotropes. This reversal in the mobilities of Sup35NM in the 
presence of strong chaotropes at pH 4.5 agrees with our aggregation data (Figure 3.12). 
Interestingly a charge reversal is also seen in the mobilities of Aβ42 at pH 4.5 however, it 
is not reflected in the aggregation data perhaps because the absolute value of the charge-
reversed mobilities are very close to zero. (Figure 3.13 and Figure 3.9). 
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Figure 3.11 – Electrophoretic mobilities of Sup35NM at pH 3.2 in the presence of 



































Figure 3.12 – Electrophoretic mobilities of Aβ42 at pH 3.2 in the presence of sodium 




































Figure 3.13  – Electrophoretic mobilities of Sup35NM at pH 4.5 in the presence of 





































Figure 3.14 – Electrophoretic mobilities of Aβ42 at pH 4.5 in the presence of sodium 
salts of monovalent anions 
 
3.5 Discussion 
The effect of anions on the aggregation of both Sup35NM and Aβ42 can be evaluated 
in terms of specific and non-specific effects arising from electrostatic and hydrophobic 
interactions, and preferential interactions or solvent (hydration) effects. The isoelectric 





































charge below a pH of 5.3 and a net negative charge above it. The N and C terminals of the 
proteins and the polar charged residues can play a role in electrostatic interactions with the 
ions in solution. These include Lysine (Lys), Arginine (Arg), Histidine (His), Aspartic acid 
(Asp), and Glutamic acid (Glu). The number of these charged amino acids in both 
Sup35NM and Aβ42, and their amyloid fold forming domains (Sup35N and Aβ15-42) are 
shown in Table 1. For complete amino acid composition and other relevant properties see 
Appendix B. 
Table 1 – Number of charged amino acid residues in Sup35NM and Aβ42, and their 
amyloid forming domains 
Amino acids 
(pKa of side 
chain) 
Aβ1-42 Aβ15-42 Sup35NM Sup35N 
Arg (12.48) 1 0 2 2 
Asp (3.65) 3 1 9 2 
Glu (4.25) 3 1 22 0 
His (6.0) 3 0 1 0 
Lys (10.53) 2 2 25 1 
 
At a pH of 7.4, Lys and Arg are expected to be protonated and will carry positive 
charges while Asp and Glu will be deprotonated and will carry negative charges. At a pH 
of 4.5, His will also be protonated in addition to Lys and Arg. At pH 3.2, Asp and Glu will 
become protonated and will lose their negative charges. Therefore, the charge distribution 
on the proteins chages depending on the pH of the solution. Further, the local environment 
can also affect the pKa and the charge on individual amino acid side chains. It is important 
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to note that most of the charged residues in Sup35NM are present in the M domain which 
does not take part in the amyloid fiber formation. However, as per the proposed parallel in-
register structure of Sup35NM fibrils the M-domains of adjacent molecules are in close 
proximity to each other and can play a crucial role in allowing or hindering the N-domain 
in forming fibers [13, 24]. 
Further, the Grand Average of Hydropathicity (GRAVY) scores calculated for 
Sup35NM and Aβ42 indicate that Aβ42 with a GRAVY value of 0.205 is much more 
hydrophobic in nature than Sup35NM with a calculated GRAVY value of -1.596 [25] 
(Appendix B). Recent work on determining the structure of Aβ42 monomer in the fibrillar 
form has shown that Aβ42 fibers consist of two molecules per layer forming dimers 
arranged in parallel-in-register orientation. The dimer is assembled such that the 
hydrophobic residues are maximally buried while only the hydrophilic sides chains are 
exposed to the solvent. This suggests that aggregation of Aβ42 is driven by the hydrophobic 
effect [11, 12]. 
Besides electrostatic and hydrophobic interactions, competing preferential 
interactions between the protein, ions, and water can play a crucial role in governing the 
fibrillation kinetics. While small strongly hydrated kosmotropes are generally considered 
to act by exerting an excluded volume effect, large weakly hydrated chaotropes are thought 
to interact directly with hydrophobic regions on a protein [26-31]. Interestingly, in a study 
of ion interaction with an uncharged 600-residue elastin like polypeptide, chaotropic anions 
were shown to mainly interact with the polypeptide backbone while no significant binding 
of  the ions to the hydrophobic side chains was detected [32]. In another work, chaotropes 
were shown to interact with the peptide backbone of a triglycine model peptide [18]. This 
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suggests that besides the specific residues in a protein the peptide backbone or the length 
of the protein can have a significant impact on the overall effect of ions on protein stability 
and aggregation tendency. 
Ions can also act by screening electrostatic forces (Debye-Hückel effects). 
Screening effects are non-specific in nature and depend on the ionic strength of the 
solution. While electrostatic effects resulting from ion interaction with specific charges on 
the protein are expected to be dominant at low ionic concentrations, the observed effects 
at high concentration are due to an interplay of ion-specific Hofmeister effects and non-
specific screening effects.  
At pH 7.4, both the Sup35NM and Aβ42 are negatively charged and anions act as 
co-ions. Kosmotropes which are excluded from the protein-water interface increase the 
surface tension and destabilize the monomeric protein resulting in faster fiber formation 
similar to their effect on globular proteins. Chaotropes, on the other hand, preferentially 
interact with the hydrophobic regions on the proteins and the polypeptide backbone, and 
result in stabilization against aggregation. As a result, at a particular ionic strength the 
relative effects of kosmotropes and chaotropes on aggregation are in the same direction for 
both Sup35NM and Aβ42 and are correlated with the position of the ions in the Hofmeister 
series. In summary, at the same salt concentration aggregation is the fastest in the presence 
of the most kosmotropic ion, SO42-, and slowest in the presence of the most chaotropic ion, 
ClO42-, as seen in Figure 3.3 and Figure 3.4.  
The main difference in the effect of ions on the fibrillation kinetics of Sup35NM 
and Aβ42 at pH of 7.4 is that an increase in the concentration of the salts, promotes the 
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fibrillation of Aβ42 irrespective of whether the anion is a kosmotrope or a chaotrope. On 
the other hand, increase in the concentration of chaotropic anions hinders the fibrillation of 
Sup35NM while increase in the concentration of kosmotropes promotes fiber formation. 
This suggests that the fibrillation of Aβ42 is dominated by screening effects and is less 
sensitive to direct interaction of ions with the protein. On the other hand, interaction of 
chaotropic ions with Sup35NM disrupts the recognition landscape for templating and 
hinders fiber formation effectively suggesting that Sup35NM interaction is driven by 
specific electrostatic interactions. 
One possible explanation for this observation invokes a two-step process of nucleus 
formation where the first step is initial agglomeration of monomers to form a ‘pre-
organized’ oligomeric intermediate followed by conformational conversion or structural 
reorganization to an organized stable nucleus. Ions can affect these steps through different 
mechanisms. An increase in ionic strength is likely to promote the agglomeration step 
through screening effects while ion-specific binding may affect the conformational 
conversion to form a stable nucleus. Binding of chaotropes to the protein will likely hinder 
conformational conversion of the oligomer to the nucleus by disrupting the recognition 
landscape. Since, screening effects due to increase in ionic strength dominate over ion-
specific effects, it suggests that the first agglomeration step is the rate limiting step in Aβ42 
fibrillation.   
In the case of Aβ42 most of the protein is involved in a cross-beta structure and 
initial agglomeration is frequently followed by conformational conversion, because once 
the molecules are brought together, they begin interacting and forming a cross-beta 
structure. On the other hand, the conformational conversion to the nucleus may be the rate-
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limiting step in the aggregation of Sup35NM as the process is highly sensitive to specific 
ion binding. Sup35NM contains a long M-domain region which is not involved in the 
amyloid core but needs to be in the proper orientation and conformation that favors nucleus 
formation. Due to the presence of this long extra domain, initial agglomeration is highly 
reversible and may not always lead to conformational conversion, which requires 
interactions between specific residues within the amyloid core domain.  
Our observations can also be explained by the previously observed dual ‘salting-
in’ and ‘salting-out’ behavior of chaotropes [33]. At pH 7.4, Aβ42 has only 3 positively 
charged residues and a much shorter backbone than Sup35NM. It is possible that the sites 
for chaotrope binding become saturated in Aβ42 and a further increase in ionic strength 
leads to an excluded volume effect resulting in faster fibrillation similar to ‘salting-out’ of 
globular proteins by chaotropes at high concentrations. Nevertheless, at pH 7.4 the more 
chaotropic ions still manage to absorb more effectively to Aβ42 resulting in greater negative 
charge on Aβ42 than in the presence of the less chaotropic anions and kosmotropes.  This 
explains why the relative effect on fibrillation still correlates with the position of the ions 
in the Hofmeister series. On the other hand, Sup35NM has about 27 positively charged 
residues and a much longer peptide backbone providing more sites for chaotropic anions 
to bind as compared to Aβ42. It is possible that the binding sites on Sup35NM are not 
completely occupied and an increase in chaotrope concentration results in delayed 
aggregation due to further stabilization of the monomer similar to ‘salting-in’ of globular 
proteins at relatively moderate chaotrope concentrations. 
The effect of ions on the fibrillation of Sup35NM and Aβ42 at acidic pH values can 
be explained by electrostatic interactions. At pH less than the pI, the proteins are positively 
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charged and the anions act as counter-ions. At pH 3.2 and 4.5, kosmotropes act in the same 
way as at pH 7.4, by exerting depletion forces through an excluded volume effect, 
chaotropic anions, on the other hand, interact directly with specific residues and neutralize 
the charge on the protein, reducing repulsion between molecules and promoting fibrillation. 
Hence, we see a reversal of Hofmeister effect for chaotropic anions when the charge on the 
proteins is reversed (see sections 3.4.3 and 3.4.4). As we move close to the pI, at pH 4.5 
we see that there is charge inversion due to adsorption of an excess of chaotropic anions, 
resulting in slower fiber formation.  
This work shows that ions affect amyloid formation through a complex interplay of 
specific and non-specific effects comprising of electrostatic and hydrophobic interactions, 
and preferential interactions (Hofmeister effects). Through a comparison of two amyloid 
forming proteins, namely, Sup35NM and Aβ42 we have shown that the properties of the 
proteins such as the types of residues (charge and hydrophobicity) and polypeptide chain 
length play a crucial role in determining the effect of ions on stability and aggregation. 
Additionally, the main differences in the effect of ions on aggregation of Sup35NM and 
Aβ42 may suggest crucial differences in the aggregation mechanism. 
3.6 Conclusions and future work 
Chapter 3 presents a detailed investigation of the effect of ions on the aggregation of 
amyloids. We demonstrate that the effect of ions on amyloid aggregation is a complex 
interplay of the different interactions which depend on many factors such as the effective 
charges on the protein, the length of the protein, and its surface polarity. We have shown 
that while the overall effect of ions on the aggregation of the two proteins, Sup35NM and 
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Aβ42, is the same, there are important differences in the absolute effects which point to 
differences in the rate limiting steps in the aggregation of these proteins. The widely 
different properties of Sup35NM and Aβ42 such as difference in sizes, hydrophobicity, 
charged residues, and the length of the amyloidogenic domains may contribute to the 
differences in the aggregation of these proteins. Despite all these differences, the overall 
effect of anions on their aggregation is the same, which demonstrates the universality of 
ion-specific effects on proteins.  
As an extension of this work, A𝛽𝛽42 aggregates produced in the presence of ions can be 
analyzed by TEM/AFM to understand the effect of ions on the length and diameter of A𝛽𝛽42 
fibers. At pH 7.4 we see that A𝛽𝛽42 aggregation kinetics is primarily determined by the ionic 
strength, while at a particular ionic strength the kinetics correlates to the position of the 
ions along the Hofmeister series. It will be interesting to check whether at the same ionic 
strength A𝛽𝛽42 aggregates formed in the presence of kosmotropes are smaller in diameter 
and length on average, and if the ones formed in the presence of chaotropes possess a larger 
average diameter and length like Sup35NM aggregates formed under similar conditions 
[1]. Confirming if ions (kosmotropes vs chaotropes) have a similar effect on A𝛽𝛽42 fiber 
structure will imply that ions can be used as universal regulators of strain in vitro, although, 
the absolute effects are determined by a complex interplay of ion-specific effects and ionic 
strength. It will also be interesting to see how the A𝛽𝛽42 amyloid fiber structure changes 
with increase in ionic strength. Along the same lines, the thermal stability and frangibility 
of the A𝛽𝛽42 strains can also be analyzed by SDS-PAGE and SDD-AGE analysis. 
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Furthermore, the structure, stability, and frangibility of the Sup35NM and A𝛽𝛽42 aggregates 
formed at pH values below the isoelectric points can be analyzed to understand the effect 
of ions on aggregation when they act as counter-ions. When the protein is positively 
charged the kinetics in the presence of chaotropes is primarily determined by the charge 
screening and neutralization. While the properties of the fibers formed in the presence of 
kosmotropes are expected to be the same at pH 3.2 and 4.5 as at pH 7.4, the properties of 
the fibers formed in the presence of chaotropes can be expected to be determined by either 
the kinetics of aggregation (screening and neutralization effects) or by the ionic character. 
Investigating this can also help in determining whether strain conformation and type is 
determined by the kinetics or other ion-specific effects. 
Finally, the presence of a relatively large highly charged M-domain in Sup35NM may 
interfere in the aggregation process, especially during the structural reorganization stage 
during nucleus formation where the N-domain forms inter and intramolecular contacts 
resulting in the formation of the amyloid core. Therefore, it will be interesting to see how 
the addition of the M-domain of Sup35 to Aβ42 might affect its aggregation behavior. More 
specially, the effect of ions on the aggregation of Aβ42 fused with the M-domain of Sup35 
can be investigated and compared to their effect on the aggregation of Sup35NM. The 
amyloid forming region of Aβ42 comprises of residues from 15-42. The M-domain of 
Sup35 can also be fused to the amyloid core-forming residues of Aβ42 and a comparative 
study of the aggregation behavior of these fusion proteins in the presence of ions can be 
performed to improve our understanding of the contribution of the amyloidogenic and non-
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CHAPTER 4. COMPUTATIONAL MODELING OF AMYLOID 
AGGREGATION KINETICS 
4.1 Abstract 
Amyloid aggregation is a complex process involving many steps such as primary 
nucleation, elongation, and fragmentation. Many empirical and mechanism based models 
have been used to fit aggregation data obtained for different amyloid/prion proteins. 
Performing global fitting analysis of aggregation data is crucial to determine the most 
appropriate mechanism for a system. Here, we have performed a half time analysis to match 
the experimentally observed dependence of aggregation kinetics on the protein 
concentration and determine the most appropriate model for fitting our aggregation data. 
Global fitting analysis was then done to evaluate the model. We find that existing 
mechanism schemes are not suitable for fitting Sup35NM aggregation data. Even the best 
performing scheme, provided relatively poor fits to the aggregation data which suggests 
that some mechanistic details may be missing from or different in the model when 
compared to the actual aggregation mechanism of Sup35NM. In this chapter, we evaluate 
a simulation model which offers advantages such as ease of making modifications and 
including new process steps. We also discuss limitations of the model and potential sources 
of discrepancies between model predictions and experimental kinetic data collected using 





Amyloid aggregation is a complex process comprising of a number of steps which result 
in the assembly of monomeric proteins into amyloid fibers. The simplest mechanistic 
explanation of the process of amyloid formation generally consists of a two-step pattern of 
initial nucleation corresponding to a lag phase followed by a fiber elongation phase to form 
a mature fiber [1]. When the fibril mass fraction for an unseeded aggregation reaction is 
plotted with respect to time a sigmoidal curve is usually obtained. This behavior is 
generally modeled using mathematical empirical functions such as the logistic function 
(equation 1), which captures the near sigmoidal shape of amyloid aggregation [2, 3].  
 𝐹𝐹(𝑡𝑡) = 𝐹𝐹0 +
𝐴𝐴




Here,  𝐹𝐹0 is the baseline, A is the amplitude, 𝑘𝑘 is the elongation rate constant, and 𝑡𝑡1 2�  is 




However, while the logistic model is easy to apply and parameterize the data, it is not based 
upon any mechanism and cannot be used to get mechanistic insights into the aggregation 
kinetics. 
The simplest non-empirical kinetic models that have been used for fitting amyloid 
aggregation data include two-step mechanisms for fibrillation of human calcitonin, and 
human insulin, and the Finke-Watzky (F-W) 2-step mechanism [4-6]. These mechanisms 
de-convolute aggregation into a slow conformational conversion of cellular protein to the 
amyloid/prion form followed by an autocatalytic reaction resulting in typically fast 
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formation of more of the amyloid/prion form. These models share a very similar 
mathematical form, a result of the autocatalytic component of these mechanisms. However, 
it should be noted that these models do not incorporate association of molecules which is 
central to a process like amyloid formation involving polymerization of monomeric 
protein. More complex models based on a nucleation-polymerization mechanism have 
been proposed and used to fit amyloid aggregation data, however, recent work has shown 
the importance of secondary processes like fragmentation and fiber-assisted nucleation on 
the aggregation process [7-13]. Analytical solutions to models consisting of secondary 
processes like fragmentation or fiber catalyzed secondary nucleation have been obtained 
and used to fit aggregation data [14-18]. However, due to the complex nature of the 
aggregation process and differences in the aggregation mechanism of different proteins, 
different models are usually required to fit aggregation data for different proteins. Here, 
we have developed a simulation model for amyloid aggregation process which primarily 
consists of four main process steps: primary nucleation, elongation, breakage and 
secondary nucleation. We have then attempted to use the model to perform global fitting 
of Sup35NM aggregation data. The model is then modified to simulate the mechanism 
found to match the experimentally observed dependence of aggregation kinetics on protein 
concentration and improve the overall fitting. 
4.2.1 General mechanism of amyloid aggregation 
The process of amyloid aggregation starts with the formation of several primary 
nuclei from monomers (M), which then act as templates for addition of more monomeric 
protein molecules. Sequential and stepwise addition of monomers results in fiber 
elongation generating a pool of fibers of different sizes (Pi). At any stage after the formation 
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of primary nuclei, secondary processes like breakage/fragmentation and fiber-assisted 
nucleus formation generate more fiber ends or surfaces for the monomer to attach. While 
secondary nucleation can occur in both in vivo and in vitro systems by similar mechanisms, 
breakage generally occurs in in vitro systems due to agitation which causes shear, and in 
vivo systems by the action of chaperones which break down larger aggregates or fibers [19-
23]. This process can be represented in a schematic as shown below in Figure 4.1 
 
Figure 4.1 – General scheme of amyloid aggregation comprising of four fundamental 
processes, namely, primary nucleation, elongation, breakage and secondary 
nucleation. k1f and k2f are the rates of monomer addition before and after nucleus 
formation, k1r and k2r are the rate of monomer dissociation before and after nucleus 
formation, kb is the breakage or fragmentation rate, and k1f’ and k1r’ are the rates of 
forward and backward reactions for fiber-catalyzed nucleus formation. 
The main assumptions are as follows: 1) rate of monomer association, k1f, is less than 
the rate of monomer dissociation, k1r, prior to nucleus formation 2) rate of monomer 
association, k2f, is greater than the rate of monomer dissociation, k2r, after nucleus 
formation, 3) one monomer is added to a polymer at time, 4) there is no end-to-end 
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association of polymers, and 5) all steps, with the exception of fragmentation, are 
reversible. 
The above scheme was then simplified as shown below in order to reduce the number 
of parameters (Figure 4.2). Primary and secondary nucleation were considered to involve 
simultaneous association of monomers to form a stable nucleus followed by sequential 
addition of monomers resulting in fiber elongation. Breakage can occur for any fiber of the 
size larger than the nucleus. 
 
Figure 4.2 – Simplified scheme of amyloid aggregation. Here, kpn is the primary 
nucleation rate constant, kef is the rate constant for monomer association, ker is the 
rate constant for monomer dissociation, kb is the breakage or fragmentation rate 





The above scheme can be summarized in the following reactions. 




∗  (2) 
 
Fiber elongation: 
 𝑀𝑀 + 𝑃𝑃𝑛𝑛𝑐𝑐
∗ 𝑘𝑘𝑒𝑒𝑒𝑒��𝑃𝑃𝑛𝑛𝑐𝑐+1 (3) 
      ……..……..    




𝑘𝑘𝑒𝑒𝑒𝑒��𝑃𝑃𝑖𝑖 + 𝑀𝑀 (5) 
  Breakage of polymer of size i at position j: 
 𝑃𝑃𝑖𝑖
𝑘𝑘𝑏𝑏→𝑃𝑃𝑗𝑗 + 𝑃𝑃𝑖𝑖−𝑗𝑗 (4) 
   Fiber-catalyzed secondary nucleation  
 𝑛𝑛𝑐𝑐𝑀𝑀
𝑘𝑘𝑠𝑠𝑝𝑝[𝐹𝐹𝑚𝑚]�⎯⎯⎯⎯�𝑃𝑃𝑛𝑛𝑐𝑐
∗  (5) 
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 Here, M is the concentration of monomer, * indicates a nucleus, nc is the size of the 
nucleus, Pi is the concentration of polymer of size, Fm is the fiber mass concentration, kpn 
is the primary nucleation rate constant, kef is the monomer association rate constant, ker is 
the monomer dissociation rate constant, kb is the breakage/fragmentation rate constant, and 
ksn is the secondary nucleation rate constant. 
This system can then be described by the following population balance equations. 
The rate of change of nuclei concentration: 
 𝑑𝑑𝑝𝑝𝑛𝑛𝑐𝑐
𝑑𝑑𝑡𝑡
= 𝑘𝑘𝑝𝑝𝑛𝑛[𝑝𝑝1]𝑛𝑛𝑐𝑐 − 𝑘𝑘𝑒𝑒𝑒𝑒[𝑝𝑝1]�𝑝𝑝𝑛𝑛𝑐𝑐� + 𝑘𝑘𝑒𝑒𝑒𝑒�𝑝𝑝𝑛𝑛𝑐𝑐+1� + 2 × �  𝑘𝑘𝑏𝑏�𝑝𝑝𝑗𝑗�
𝑛𝑛𝑛𝑛𝑙𝑙𝑛𝑛
𝑗𝑗=𝑛𝑛𝑐𝑐+1
+ 𝑘𝑘𝑠𝑠𝑛𝑛[𝐹𝐹𝑚𝑚][𝑝𝑝1]𝑛𝑛𝑐𝑐   
(6) 
Where nMax is the maximum aggregate size, and 𝐹𝐹𝑚𝑚 =  ∑  𝑗𝑗�𝑝𝑝𝑗𝑗�𝑛𝑛𝑛𝑛𝑙𝑙𝑛𝑛𝑗𝑗=𝑛𝑛𝑐𝑐 . 




= 𝑘𝑘𝑒𝑒𝑒𝑒[𝑝𝑝1][𝑝𝑝𝑖𝑖−1]− 𝑘𝑘𝑒𝑒𝑒𝑒[𝑝𝑝1][𝑝𝑝𝑖𝑖] + 𝑘𝑘𝑒𝑒𝑒𝑒[𝑝𝑝𝑖𝑖+1]− 𝑘𝑘𝑒𝑒𝑒𝑒[𝑝𝑝𝑖𝑖]









= 2 × � 𝑘𝑘𝑏𝑏�𝑝𝑝𝑗𝑗� − 𝑘𝑘𝑝𝑝𝑛𝑛[𝑝𝑝1]𝑛𝑛𝑐𝑐 −
𝑛𝑛𝑛𝑛𝑙𝑙𝑛𝑛
𝑗𝑗=𝑛𝑛𝑐𝑐+1







4.3 Material and Methods 
4.3.1 Expression and purification of Sup35NM 
Sup35NM was expressed and purified as previously described in section 3.3.1. 
4.3.2 Fibrillation assays using Thioflavin T 
Fibrillation assays were performed as previously described in section 3.3.3. 
Thioflavin T assay was performed for a range of concentrations of Sup35NM: 0.25µM, 0.5 
µM, 0.75 µM, 1 µM, 2.5 µM, 5 µM, 7.5 µM, 10 µM, 15 µM, 20 µM, and 25 µM, in the 
presence of PBS at 37ºC in a 96-well plate with linear shaking at 18Hz in a BioTek Synergy 
H4 Hybrid Multi-Mode Microplate Reader (Winooski, VT). Fluorescence readings were 
taken every 10 minutes using an excitation wavelength of 440 nm and emission wavelength 
of 485 nm. 
4.3.3 Computational modelling of aggregation kinetics  
The system of equations was modelled as a system of matrices consisting of the 
concentration of each species at a particular time and the time derivative as follows: 
 























which is expressed as a linear combination of X based on equations (8), (9) and (10). 
The time derivative is then numerically integrated to determine the concentration of all 
species at all times. 






Detailed description of the matrix implementation is shown in Appendix C.  
The simulation is then used to fit experimental data with rate constant parameters. 
4.4 Results 
4.4.1 Fitting aggregation data with model 
The model was able to successfully fit aggregation data collected for individual 
concentrations. An example fit is shown in Figure 4.3 below. 
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Figure 4.3  – Model fit to aggregation data for 2.5 µM Sup35NM 
 However, a single experimental curve does not contain enough information to 
reliably determine all the free parameters (rate constants). To remedy this problem, we 
turned to simultaneous fits of data. But the same model comprising primary nucleation, 
elongation, breakage/fragmentation, and fiber-catalysed secondary nucleation was not able 
to fit the aggregation data obtained for several different Sup35NM concentrations 
simultaneously. Notably, the model overpredicts the sensitivity of the aggregation lag time 
on the overall protein concentration, see Figure 4.4. 























Figure 4.4 – Aggregation data obtained for different concentrations of Sup35NM and 
model simulations obtained if the model is used to fit the aggregation data obtained 
for 2.5 µM Sup35NM. Experimental data is shown in circles and model simulations 
in solid lines. 
Such a mismatch in the experimental data and the model simulation suggested that we were 
not using the appropriate model for fitting the experimental data. Generally, a scaling 
exponent (γ), obtained by plotting the logarithm of aggregation half times against the 
logarithm of protein concentration, is used as an indicator of the mechanism/model which 
is closest to the experimental data [17]. We next, obtained the γ for our data and model 
previously used as shown in Figure 4.5 
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Figure 4.5  – Scaling exponent for experimental data and model 
 We see that the γ value of the model does not match the γ value of the experimental 
data. So, we then compared the γ value of our experimental data to the expected γ values 
for different models for which analytical solutions have been made available [17]. We 
found the γ value for our system seems to lie in the range of γ values expected for a 





Table 2 – Models and their expected scaling exponent values 
Model Scaling exponent (γ) 
Nucleation-elongation -1 
Secondary nucleation -1.5 
Fragmentation -0.5 
Fragmentation and secondary nucleation -1.5 to -0.5 
Multistep secondary nucleation -1.5 to -0.5 
Saturating elongation -0.5 
Saturating elongation and secondary nucleation -1.5 to -0.5 
Saturating elongation and fragmentation -0.5 to 0 
 
Saturating elongation describes a special situation which occurs at monomer 
concentrations above a certain threshold concentration where the diffusion of monomers 
to the fibril ends is no longer rate-limiting; rather, the conformational conversion of the 
monomer after attachment to a fibril end becomes the rate limiting step [17]. The rate of 














Here, P(t) is the total polymer number concentration, M(t) is the total polymer mass 
concentration, m(t) is the monomer concentration, k+ is the elongation rate constant, k- is 
the breakage rate constant and KE is the crossover concentration above which elongation 
is rearrangement-limited. Note that the mathematical form of equation (15) is similar to the 
Michaelis-Menten equation for enzymatic reactions. Analytical solutions to the eight 
models listed in Table 2 have been obtained by Knowles and co-workers [17] who have 
also developed an online platform for fitting amyloid aggregation data, named AmyloFit 
(http://www.amylofit.ch.cam.ac.uk). We then used the saturating elongation and 
fragmentation model in AmyloFit to fit our aggregation data and compared it to fits 
obtained by incorporating the saturating elongation scenario in our simulation model. We 
were able to obtain similar results with both the tools (see Figure 4.6) 
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Figure 4.6 – Aggregation data fitted to saturating elongation and fragmentation 
model using A) AmyloFit and B) Simulation model  
From the above figure, we can see that while both the tools perform equally well, the 
saturating elongation and fragmentation model does not represent the experimental data 
very well. The model is especially not able to fit the aggregation curves towards the end of 
the aggregation period and the ascent to the plateau is much sharper for the models than 
for the experimental data. The predicted sharp ascent to the plateau was found to be 
insensitive to the chosen maximum allowable aggregate size (maximum number of 
monomers in an aggregate). The problem, therefore, was not an artifact due to the cut-off 
limit imposed on the maximum aggregate size.  
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4.5 Discussion 
Global fitting of amyloid aggregation data is necessary to arrive at the most 
appropriate mechanistic model for a given protein. While most models can fit aggregation 
kinetics at a single concentration, only the most accurate model can reproduce the 
aggregation behavior at different concentrations simultaneously. Here, we have performed 
global fitting of Sup35NM aggregation data at different concentrations using the most 
appropriate model as indicated by calculation of the scaling exponent, γ, which is generally 
used as a guide for determining the correct model. We find that while the model suggested 
by the half time analysis (saturating elongation and fragmentation) matches the expected 
dependence of half times of aggregation on the protein concentration, it is still unable to fit 
our aggregation data well. Our simulation model performs as well as the publicly available 
online tool AmyloFit; however, it appears that the model lacks crucial mechanistic details 
making it insufficient. There is a considerable mismatch between the model and the 
experimental data, especially towards the end of the aggregation where the model over-
predicts the aggregation rate considerably.  
 It is interesting to note that Aβ42 and Aβ40 peptide which only differ by 2 amino 
acids have been shown to aggregate by different mechanisms. A model comprising of 
primary nucleation, elongation, and fiber catalyzed secondary nucleation with a primary 
and secondary nucleus size of two has been successfully used to fit aggregation data for 
Aβ42, while a model with a  two-step secondary nucleation process was found to fit Aβ40 
data globally [8, 10]. It is highly likely that Sup35NM, which is a much larger protein with 
very different properties may aggregate through a different mechanism. We have discussed 
in the Chapter 3 that ions affect the aggregation of Sup35NM and Aβ42 differently which 
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points to differences in their aggregation mechanisms. A three stage mechanism 
comprising of conformation conversion, nucleation and elongation was found to fit insulin 
aggregation data [12]. Therefore, different amyloidogenic proteins appear to aggregate 
through different mechanisms and it is plausible that Sup35NM may aggregate through its 
own unique mechanism. Logically, the next step would be to test models accounting for 
other permutations and combinations of the individual sub-processes and use them to 
perform global fitting of the aggregation data. 
 Other possible reasons for the model not being able to fit the aggregation data 
include crowding due to high concentration of large aggregates especially for high 
concentrations. This can lead to diffusional limitations as well as excluded volume effects. 
Diffusional limitations due to crowding may dominate over excluded volume effects if the 
kinetic bottleneck is the process of diffusion and collision between the monomer and fibril 
end. Such a situation is likely for proteins which have a high tendency to aggregate. For 
such proteins, macromolecular crowding is much less efficient in accelerating peptide self-
association. Diffusion of monomeric protein in a solution of protein polymers of different 
sizes is a complicated process. At high concentrations, amyloids can form a polymer gel 
like network which can obstruct diffusion of monomeric protein. Another plausible reason 
for the mismatch could be the dependence of the length of aggregate/polymer on their 
diffusivities and hence the rate constants. And finally, it is possible that crowding and 
entanglement of polymers to form a gel could interfere with binding of the dye to the 
aggregates resulting in a non-linear dependence of the fluorescent signal with the fiber 
concentration.  
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It is important to note here that analytical solutions are available only for the models 
listed in Table 2. These models represent a subset of the mechanisms that can occur. The 
lack of analytical solutions to other combinations of processes points to the difficulty in 
obtaining analytical solutions to these systems which become more and more complex as 
more steps are introduced. However, our simulation model presents certain advantages 
over analytical models which are listed below: 
1) Any step/process/limiting situation such as two-step secondary nucleation, 
saturating elongation, etc., can be incorporated in the model relatively easily.  
2) Any combination of sub-processes can be modelled. 
3) The model provides population balance distributions which can be verified using 
other techniques such as TEM/AFM analysis of aggregates formed over the course 
of the reaction. This can provide an additional verification of the model. 
4) The model allows us to vary the primary and secondary nucleus size, and the 
smallest detectable size independently. Therefore, data collected using other dyes 
can also be used for fitting and to ensure the validity of the model. 
4.6 Conclusions and future work 
Here, we have developed a tool for modelling of amyloid aggregation kinetics using 
a simulation approach. The model offers many advantages over analytical models which 
make it a versatile tool for testing any mechanism. A closed form solution, which can be 
difficult to obtain for complex mechanisms, is not required for such a simulation model. 
The model also provides a distribution of different species with respect to time which is 
not provided by an analytical solution based model.  
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We find that the most suitable model suggested by half time analysis is inadequate 
for fitting our Sup35NM aggregation data as it overpredicts that rate of aggregation 
especially towards the end of the aggregation process. Analytical solution based models 
have been successfully used to fit Aβ42 and Aβ40 aggregation data collected at different 
concentrations simultaneously, and the most appropriate mechanisms for the aggregation 
of these peptides have been established [8, 10]. Therefore, fitting Aβ42 and/or Aβ40 
aggregation data with our simulation model, tailored to the mechanism of aggregation of 
these peptides, can provide a sanity check for our model. If the model can predict and fit 
aggregation of amyloid beta peptides, then it will indicate that such a simulation based 
implementation of amyloid aggregation is at par with existing analytical models.  
The current inability of the available analytical models and our simulation model to 
fit Sup35NM aggregation data indicates that a crucial detail is missing in the mechanism. 
The next logical step is to test different combinations of the underlying processes to fit the 
data. Another approach would be to resort to our general amyloid aggregation scheme and 
introduce reversibility back in the nucleation process. The aggregation process can be 
considered to consist of a stepwise process of monomer addition (forward reaction) and 
monomer dissociation (reverse reaction) till an aggregate of the size of nucleus is formed, 
after which the rate of monomer association is more favorable than the rate of monomer 
dissociation. Alternatively, the nucleation process can be modelled as a simultaneous 
association of monomers to form an intermediate of the size of nucleus, which can 
dissociate into its constituent monomers, followed by conformational conversion of the 
intermediate to the nucleus. Similarly, the effect of introduction of an additional step 
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involving conformational conversion cellular monomer to the amyloid form before or after 
attachment to the fiber can be investigated. 
Finally, other phenomena such as crowding and formation of a gel like network of 
polymers can also result in a mismatch between the experimental data and the model 
simulation due to diffusional limitations. The dependence of rate constants on some these 
effects can also be incorporated into the model to improve fitting. 
Once an appropriate model has been determined, global fitting of aggregation data 
obtained in the presence of different ions can provide useful insights such as whether the 
presence of co-solutes such as ions results in a change in the mechanism of aggregation. If 
there is no change in mechanism, then fitting experimental data collected in the presence 
of varying concentration of ions can tell us how the rates of reactions of the underlying 
fundamental processes are affected by the presence of different ions along the Hofmeister 
series. This can provide a clue to the mechanism of action of the ions. Further, the effect 
of shaking on the aggregation kinetics can also be studied to de-convolute the effect of 
shaking on breakage of fibers and fiber-catalyzed secondary nucleation. 
Such a model can be a very powerful tool in determining the appropriate mechanism 
of aggregation of a particular protein using global fitting analysis. Once the most correct 
model is determined, it can be used to understand the effect of different environmental 
conditions on the aggregation mechanism and/or kinetics. It can also be used to determine 
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CHAPTER 5. CONCLUSIONS, PERSPECTIVES, AND FUTURE 
RECOMMENDATIONS 
Proteins are an important class of functional biomolecules. Most of the biological 
functions in the human body are performed by proteins. Proteins in the form of enzymes, 
vaccines, antibodies etc. also comprise a large sector of the biopharmaceutical industry. 
The functionality of protein molecules is integrally tied to their structure. Therefore, proper 
folding into their functional folded state is crucial for optimal biological activity and to 
maintain the efficacy of protein based pharmaceutical products. The deleterious effects of 
improper folding and aggregation of proteins have been discussed earlier in this thesis. To 
effectively prevent misfolding/unfolding and aggregation it is crucial to understand these 
adverse processes as well as the factors which promote or inhibit them. This thesis explores 
the influence of ions on the aggregation behavior of amyloids. The insights from this work 
not only aid towards a better understanding of amyloid aggregation but also can be useful 
to predict and prevent aggregation of proteins during production, storage, and transport in 
the biopharmaceutical industry. Ions are ubiquitous in biology and are also important 
components of many solutions like buffers and stabilizer solutions that are frequently used 
in the biopharmaceutical industry where ion-specific effects may give rise to problems like 
aggregation [1]. The co-existence of ions with biological proteins as well as 
biopharmaceutical products makes it important to study the influence of ions on protein 
aggregation. Moreover, ions can pass the blood-brain barrier (BBB) and affect the 
amyloidogenic proteins present in the central nervous system that are involved in 
neurodegenerative diseases. For example, lithium carbonate, which was prescribed as a 
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drug for mood disorders, has been shown to cross the BBB. This highlights the importance 
of studying the effect of ions on amyloid formation [2]. 
Building on the previous work by our group on ion-specific effects on amyloid 
aggregation and strain formation [3], we have shown in Chapter 2 of this thesis that ions 
can also regulate cross-species prion transmission. The results presented in this work 
highlight the relative contributions of protein sequence, prion strain, and environment on 
species barrier. We have shown that ions present during co-aggregation have a systematic 
influence on the barrier while ions used to form the donor or seed amyloid can affect the 
barrier specificity. An important follow up question that arises from this investigation is 
whether the resulting morphology of the aggregates formed after seeding is dictated by the 
environment of aggregation or the seed strain. Such an investigation would reveal how 
faithfully the amyloid seed conformation is adopted and propagated when the environment 
of aggregation is altered from the conditions which were initially used to form the seed. 
Chapter 3 of this thesis entails a systematic investigation of the effect of ions on 
amyloid aggregation by two different amyloid proteins, Sup35NM and Amyloid β-42. We 
show that ions can have varied effects on amyloid formation by these proteins. pH of the 
solution also plays an important role in determining the how ions interact with proteins in 
solution, thereby affecting the aggregation kinetics. While ion-protein interactions follow 
expectations per the relative positions of the ions in the Hofmeister series for both proteins, 
the absolute effects on the aggregation kinetics of the two proteins are not always similar. 
This suggests that there may be differences in the mechanisms of aggregation of these 
proteins. An interesting question which arises from this study is what is the degree to which 
amyloid conformation and morphology are determined by the ionic strength of the solution 
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vs the identity of the ions (or the environment)? Investigation of the morphology of the 
amyloids formed by Sup35NM and Aβ₄₂ in the presence of varying concentrations of 
different ions and at varied pH values can shed light onto this question. If ion 
identity/character is the primary determinant of the morphology then we can expect the 
morphology to be different in the presence of kosmotropic and chaotropic ions (as 
previously observed for Sup35NM [3]). On the other hand, if the morphology is primarily 
determined by ionic strength then we can expect changes in the amyloid morphology to be 
related to increase or decrease in ionic strength irrespective of ion identity/character. It 
would also be worthwhile to investigate the effect of other environmental factors which 
affect the aggregation kinetics to ascertain the primary determinant of amyloid structure. 
For example, the effect of temperature on various amyloidogenic proteins has been widely 
studied and increase in temperature has been reported to promote faster kinetics [4-6]. 
Interestingly, however, Sup35NM aggregates with a ‘strong’ phenotype and low thermal 
stability were formed at a low temperature of 4ºC (which is expected to result in slow 
kinetics), whereas Sup35NM aggregates with a ‘weak’ phenotype and high thermal 
stability were observed at a high temperature of 37ºC (which is expected to result in fast 
kinetics) [6]. These are contrary to our group’s previous observations that fast Sup35NM 
aggregation kinetics correlated with a ‘strong’ phenotype and low thermal stability and 
vice versa [3]. While phenotype and thermal stability may be related to morphology such 
that we expect aggregates with a ‘strong’ phenotype and low thermal stability to have 
smaller and shorter fibers and vice versa, it is still necessary to image the aggregates to 
ascertain their morphology. Therefore, a similar detailed investigation of the effect of other 
factors such as temperature, agitation, other non-ionic co-solutes etc. on kinetics and 
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morphology and physiochemical properties of aggregates might conclusively answer the 
question that we have posed above.  
Moreover, a plausible explanation for the differences in the aggregation behavior 
of Sup35NM and Aβ₄₂ proposed in Chapter 3 favors a non-classical two-step nucleation 
process over the classical one-step process of nucleation. While experimental corroboration 
of either nucleation process is an extremely challenging task, it may be possible to provide 
some confirmation with the help of a computational model that fits the aggregation data. 
Computational models based on the kinetics of aggregation have been used to ascertain the 
most likely aggregation mechanisms of different proteins [7, 8]. In this work, we have also 
attempted to develop a computational model for Sup35NM aggregation kinetics. While 
amyloid aggregation in the most general sense is considered to follow a nucleation-
polymerization mechanism, there may be subtle differences in the individual processes like 
nucleation, elongation, and secondary processes for different amyloidogenic proteins. 
Kinetic models that successfully fit aggregation data can be used to gain insights into the 
most likely mechanism of aggregation. Here, we have developed a simulation based model 
which can be modified to suit any mechanism. A logical future step would be to include 
the two-step process of nucleus formation involving agglomeration of monomers to form 
a pre-defined oligomer followed by conformation conversion to form the nucleus [9]. 
Modification of the nucleation step of our best performing model mechanism, saturated 
elongation and fragmentation, into a two-step nucleation process may reduce the mismatch 
between the experimental data and the model.  
Finally, a rewarding activity would be to compile the effects of ions of the 
Hofmeister series on amyloidogenic as well as non-amyloidogenic proteins in a form 
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similar to the Hofmeister phase diagram for colloidal particles [10]. This would entail 
literature search for previously observed effects as well as a similar systematic analysis of 
the effect of ions on other proteins as performed in this work. This would help to cluster 
proteins with similar behavior together which might help uncover other patterns or 
similarities and, thus, aid in understanding some of these ion-specific effects which are not 
yet clearly understood in the context of complex protein molecules. It could also be used 
to make predictions which can be verified through experiments. 
In summary, this thesis advances the understanding of the effect of ions on 
aggregation of amyloids/prions and cross-species prion transmission through detailed 
investigations as described in Chapters 2 and 3, and provides a modelling framework for 
fitting amyloid aggregation data as discussed in Chapter 4. The significance of this work 
is two fold. Primarily it provides a better understanding of the fundamentals of amyloid 
formation and propagation, which may one day help in the development of more effective 
drugs/therapies for amyloid/prion diseases. Moreover, this knowledge can be applied to 
prevent the formation of protein aggregates in the biopharmaceutical industry and help in 
the development of safer biopharmaceuticals. 
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APPENDIX A. SEQUENCE ALIGNMENTS 
 The N-domains of Sup35 protein from Saccharomyces cerevisiae, Saccharomyces 
paradoxus, and Saccharomyces bayanus were aligned using ClustalW. 
 
Figure A.1 – Sequence alignment of Sup35N from S. cerevisiae, S. paradoxus, and S. 
bayanus  
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APPENDIX B. COMPARISON OF SUP35NM AND AMYLOID BETA 
-42 AMINO ACID COMPOSITION 
Table 3 – Amino acid composition and some properties of Sup35NM and Aβ42 and 
their amyloidogenic domains calculated using ProtParam 
 
Aβ1-42 Aβ15-42 Sup35NM Sup35N 
Ala 4 3 16 6 
Arg 1 0 2 2 
Asn 1 1 27 20 
Asp  3 1 9 2 
Cys 0 0 0 0 
Gln 1 1 41 35 
Glu 3 1 22 0 
Gly 6 5 23 21 
His 3 0 1 0 
Ile 3 3 3 0 
Leu 2 2 8 1 
Lys 2 2 25 1 
Met 1 1 2 1 
Phe 3 2 4 3 
Pro 0 0 14 6 
Ser 2 1 15 5 
Thr 0 0 11 0 
Trp 0 0 0 0 
Tyr 1 0 20 20 
Val 6 5 10 0 
Total number of residues 42 28 253 123 
pI 5.31 6.07 5.3 7.81 
Aliphatic Index 97.38 132.14 34.74 8.05 
GRAVY 0.205 1.086 -1.596 -1.915 
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APPENDIX C. MATRIX IMPLEMENTATION OF THE 
AGGREGATION SIMULATION MODEL 
The initial matrix implementation of the model comprising of nucleation, elongation, and 
fragmentation and its MATLAB code was developed by Harrison B. Rose. Below is a 
matrix implementation of the initial model plus secondary nucleation. The case of 
saturating elongation has been discussed at the end of this section. 
Rate constant of formation of 𝑛𝑛𝑖𝑖 from size below plus monomer and nucleation 
𝑘𝑘1(𝑙𝑙𝑙𝑙𝑛𝑛𝑙𝑙𝑡𝑡ℎ) = �
0, 𝑙𝑙𝑙𝑙𝑛𝑛𝑙𝑙𝑡𝑡ℎ < 𝑛𝑛𝑐𝑐

































































𝑘𝑘1(1) 0 0 0 ⋯ 0 0
0 𝑘𝑘1(2) 0 0 ⋯ 0 0
0 0 𝑘𝑘1(3) 0 ⋯ 0 0
⋮ ⋮ ⋮ ⋮ ⋱ ⋮ ⋮
0 0 0 0 ⋯ 𝑘𝑘1(𝑚𝑚𝑚𝑚𝑚𝑚 − 2) 0














































Rate constant of formation of 𝑛𝑛𝑖𝑖 by breakage of all sizes > nc 
𝑘𝑘𝑏𝑏(𝑙𝑙𝑙𝑙𝑐𝑐𝑚𝑚𝑡𝑡𝑖𝑖𝑙𝑙𝑛𝑛, 𝑙𝑙𝑙𝑙𝑛𝑛𝑙𝑙𝑡𝑡ℎ) = 2 ∗ �






� ,                    𝑙𝑙𝑙𝑙𝑐𝑐𝑚𝑚𝑡𝑡𝑖𝑖𝑙𝑙𝑛𝑛 > 1







































































0 0 𝑘𝑘𝑏𝑏(2,3) 𝑘𝑘𝑏𝑏(2,4) ⋯ 𝑘𝑘𝑏𝑏(2,𝑚𝑚𝑚𝑚𝑚𝑚 − 1) 𝑘𝑘𝑏𝑏(2,𝑚𝑚𝑚𝑚𝑚𝑚)
0 0 0 𝑘𝑘𝑏𝑏(3,4) ⋯ 𝑘𝑘𝑏𝑏(3,𝑚𝑚𝑚𝑚𝑚𝑚 − 1) 𝑘𝑘𝑏𝑏(3,𝑚𝑚𝑚𝑚𝑚𝑚)
0 0 0 0 ⋯ 𝑘𝑘𝑏𝑏(4,𝑚𝑚𝑚𝑚𝑚𝑚 − 1) 𝑘𝑘𝑏𝑏(4,𝑚𝑚𝑚𝑚𝑚𝑚)
⋮ ⋮ ⋮ ⋮ ⋱ ⋮ ⋮
0 0 0 0 ⋯ 0 𝑘𝑘𝑏𝑏(𝑚𝑚𝑚𝑚𝑚𝑚 − 1,𝑚𝑚𝑚𝑚𝑚𝑚)





























Rate constant of loss of 𝑝𝑝𝑖𝑖 by breakage to smaller sizes 




Note that we count only up to the floor (rounding down) of half of the polymer length, so 

































































0 𝑘𝑘2(2) 0 0 ⋯ 0 0
0 0 𝑘𝑘2(3) 0 ⋯ 0 0
0 0 0 𝑘𝑘2(4) ⋯ 0 0
⋮ ⋮ ⋮ ⋮ ⋱ ⋮ ⋮
0 0 0 0 ⋯ 𝑘𝑘2(𝑚𝑚𝑚𝑚𝑚𝑚 − 1) 0






























Rate constant of loss by formation of polymer of one size above 
𝑘𝑘3(𝑙𝑙𝑙𝑙𝑛𝑛𝑙𝑙𝑡𝑡ℎ) = �
𝑝𝑝1
𝑛𝑛𝑐𝑐−1 ∗ (𝑘𝑘𝑝𝑝𝑛𝑛 + 𝑘𝑘𝑠𝑠𝑛𝑛𝐹𝐹𝑛𝑛), 𝑙𝑙𝑙𝑙𝑛𝑛𝑙𝑙𝑡𝑡ℎ = 𝑛𝑛𝑐𝑐 − 1

































































0 𝑘𝑘3(2) 0 0 ⋯ 0 0
0 0 𝑘𝑘3(3) 0 ⋯ 0 0
0 0 0 𝑘𝑘3(4) ⋯ 0 0
⋮ ⋮ ⋮ ⋮ ⋱ ⋮ ⋮
0 0 0 0 ⋯ 𝑘𝑘3(𝑚𝑚𝑚𝑚𝑚𝑚 − 1) 0






























kpn is the primary nucleation rate constant, 
kef is the monomer association rate constant,  
ker is the monomer dissociation rate constant, 
 121 
kb is the breakage rate constant 
ksn is the secondary nucleation rate constant, 
Fm is fiber mass fraction 
𝑛𝑛𝑐𝑐 is the nucleus size 




where Ke is the crossover concentration above which structural organization of the 
monomer for attachment to the fiber becomes rate limiting. 
 
